rfhg_157267.1

Basic information about the TSS

---

TSS ID: rfhg_157267.1 Species: human Chr: chr12		Start: 120770270 End: 120770270 Strand: -
Source datasets	EPD
Protocol	TSS_database
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000392495.7:133 GeneID: 121665 HGNC/MGI_ID: HGNC:30424 UniProt_ID: Nearer transcript ids and distances:

Gene_name: signal peptide peptidase like 3 Gene_symbol: SPPL3 Gene_synonyms: DKFZP586C1324 IMP2 MGC126674 MGC126676 MGC90402 PSL4 Gene_source: HGNC:30424

TATA-Box annotation

---

Distance to TSS:	44444
Nearest PromoterID:	NM_000017
Entrez ID:	35
Nearest Unigene:	Hs.507076
Nearest Refseq:	NM_000017
Nearest Ensembl:	ENSG00000122971
Gene Name:	signal peptide peptidase like 3
Gene Alias:	ACAD3|SCAD
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SPPL3 p2@SPPL3 p3@SPPL3 p4@SPPL3 p5@SPPL3 p6@SPPL3 p7@SPPL3
Sample		p1@SPPL3	p2@SPPL3	p3@SPPL3	p4@SPPL3	p5@SPPL3	p6@SPPL3	p7@SPPL3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	12.27	17.92	1.56	0.78	2.14	0.58	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	10.72	18.61	1.62	0.61	3.44	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	9.84	18.90	1.16	0.77	2.70	0.77	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	7.90	10.81	1.46	0.83	3.33	0.83	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	11.25	16.20	1.57	0.22	2.70	0.45	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	10.47	14.34	2.71	0.39	2.91	0.39	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	12.42	21.13	1.96	0.65	3.05	0.44	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	11.87	12.60	3.39	0.48	4.84	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	9.83	15.39	3.42	1.07	2.56	0.85	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	4.64	22.03	4.64	1.16	1.16	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	12.53	17.38	3.23	1.21	1.21	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	10.57	15.45	3.25	0.41	2.03	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	15.47	7.58	1.77	1.45	1.45	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	9.47	5.71	1.35	1.05	0.60	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	14.49	10.76	2.20	2.42	2.42	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	13.58	11.07	1.01	1.51	2.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	16.38	7.64	1.09	1.31	1.09	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	9.70	8.86	1.27	0.84	1.27	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	11.20	3.20	1.60	1.07	0.53	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	10.83	7.37	1.05	1.20	0.90	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	10.83	4.95	0.80	1.20	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	14.50	5.01	1.38	1.55	1.73	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.69	6.46	1.29	1.68	0.90	0.13	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	11.41	7.04	1.70	2.67	2.18	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	13.42	7.74	1.03	2.32	0.52	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	12.34	5.06	0.95	0.95	2.22	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.44	6.59	0.00	0.55	2.75	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	14.85	7.78	1.41	0.94	1.89	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	11.31	6.14	1.45	2.26	1.62	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	14.12	8.87	1.63	2.17	0.36	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	11.10	5.65	1.05	1.05	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	8.60	5.47	1.17	1.37	1.37	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.55	5.28	1.69	1.90	1.06	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	9.07	4.95	1.65	0.16	0.99	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	10.85	4.67	0.93	0.75	0.93	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	11.69	7.47	1.15	0.57	1.53	0.19	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	11.04	7.36	0.82	1.02	0.82	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	10.88	4.84	0.81	1.21	0.81	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	12.42	3.78	1.08	1.35	1.08	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.16	4.80	1.68	0.48	0.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	8.70	5.18	1.18	1.41	1.18	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	7.32	4.39	0.73	0.88	1.02	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	8.65	4.64	1.27	1.69	1.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	11.36	5.07	1.75	1.40	0.70	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	12.85	6.42	2.21	1.20	2.21	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	9.77	5.12	1.16	1.63	0.93	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	10.80	7.44	0.48	2.40	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.64	4.17	1.19	2.68	1.19	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	8.62	4.79	0.96	2.15	1.44	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	8.29	4.04	2.02	1.82	1.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	9.02	2.66	1.23	1.23	2.25	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	12.68	5.56	0.89	0.89	1.33	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	10.65	6.03	0.71	1.77	1.77	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	6.96	3.31	3.65	1.66	1.66	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	10.07	2.52	0.84	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	2.76	1.38	0.92	0.92	0.92	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	13.94	3.89	1.30	0.97	2.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	10.28	3.53	0.64	1.28	1.61	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	8.49	1.57	0.94	0.94	0.63	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	8.46	7.05	0.00	0.71	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.22	6.17	1.68	0.00	3.36	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	12.74	4.78	0.00	0.80	3.98	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	4.08	2.38	0.68	0.34	1.36	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	13.97	5.20	0.97	1.30	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.71	7.10	1.06	1.77	1.42	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	12.19	5.85	0.49	0.00	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	14.38	2.98	0.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	4.69	5.16	0.47	0.00	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	4.31	2.65	0.33	0.33	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.83	6.50	0.31	0.00	1.86	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.64	6.11	0.61	1.22	1.22	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	9.50	5.86	1.11	0.79	0.95	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	8.66	8.82	0.64	2.25	0.96	0.32	0.32
Adipocyte - omental, donor1	11473-119C6	9.41	7.76	1.27	1.15	2.16	0.13	0.13
Adipocyte - omental, donor2	11474-119C7	8.22	3.74	0.75	0.75	1.49	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	14.40	2.68	1.00	0.33	2.01	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	7.66	8.29	0.00	0.64	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	4.40	2.20	1.10	1.10	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	6.77	3.16	1.35	0.45	2.26	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	12.69	11.12	1.04	1.22	1.22	0.17	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	19.36	10.37	2.35	2.74	2.74	0.39	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	22.13	8.49	2.32	1.29	0.51	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	21.74	11.15	2.23	1.39	2.51	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	19.99	11.17	2.35	1.76	2.35	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	12.79	10.22	1.93	1.13	1.77	0.16	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	16.78	7.75	0.32	0.65	0.97	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	14.40	8.53	1.07	1.07	2.67	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	13.91	10.02	1.11	2.78	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	14.14	12.89	0.83	2.50	2.08	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	13.56	9.54	0.75	0.25	2.26	0.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	12.44	6.22	0.98	0.98	2.95	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	12.79	3.96	2.13	0.91	0.61	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	10.39	5.97	1.33	0.44	2.21	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	15.42	6.45	0.72	0.72	1.79	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	3.59	0.00	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	12.95	5.40	0.36	1.08	1.80	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	5.02	0.00	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	15.20	4.31	1.03	3.70	1.44	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	16.25	8.58	1.26	2.29	1.72	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	15.67	6.86	1.22	3.18	1.22	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	7.19	0.45	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	10.85	2.17	0.00	0.43	1.74	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	2.14	8.56	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	10.76	2.99	0.30	0.30	0.30	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	8.85	3.79	0.00	0.00	1.26	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	1.32	1.32	0.00	0.00	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.15	1.95	0.32	0.32	0.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	9.71	4.85	0.49	0.49	0.97	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	7.72	2.38	0.59	0.00	2.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	7.91	4.52	0.38	1.13	1.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.08	5.08	1.45	0.73	1.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	1.25	7.52	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	9.55	4.94	0.66	0.49	0.82	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	0.00	0.00	1.36	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	6.63	5.73	0.60	0.75	1.21	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	9.64	2.14	0.00	0.54	1.61	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	10.39	6.23	0.57	0.57	2.08	0.19	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	7.75	5.61	0.00	0.80	1.07	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	10.73	5.85	0.00	0.00	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.46	4.48	0.17	2.16	1.16	0.00	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	12.01	6.00	2.40	0.00	2.40	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	0.00	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	7.55	4.29	0.51	1.03	1.54	0.00	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	9.71	2.91	0.00	0.49	1.94	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.21	6.07	0.38	1.52	0.76	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	6.06	0.00	2.42	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	11.40	1.14	0.57	1.14	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	10.26	4.06	0.21	1.50	0.86	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	8.00	3.36	0.26	0.26	1.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.04	6.10	0.00	0.00	2.82	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	8.04	4.18	0.32	0.32	0.96	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.13	4.28	0.00	0.00	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	11.11	1.17	0.00	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	9.03	3.01	0.00	0.60	0.90	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	4.75	4.75	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	7.12	3.56	0.51	0.51	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	6.62	3.06	0.25	0.25	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.72	6.35	0.00	0.64	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.49	5.18	0.43	1.73	1.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	5.93	4.87	0.00	0.64	0.85	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.09	2.90	0.00	0.87	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	18.89	2.83	0.00	0.94	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.48	3.05	0.51	0.68	1.02	0.00	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	6.95	2.32	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	2.11	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	11.36	5.57	0.43	0.43	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	7.82	5.41	0.60	0.60	1.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	12.39	2.19	1.46	1.46	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	10.80	5.75	0.46	0.46	0.46	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	7.12	5.85	0.00	0.25	1.78	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	10.94	5.16	0.62	1.24	0.83	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.04	4.59	0.92	1.22	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	9.56	5.26	0.00	1.43	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	8.65	4.88	0.89	0.89	2.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	6.10	6.10	1.53	1.53	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	7.20	1.11	0.55	0.00	2.22	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	6.09	3.97	0.53	0.53	1.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.82	4.00	1.45	0.73	0.73	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	12.53	7.98	1.11	0.86	0.98	0.12	0.49
Astrocyte - cerebellum, donor2	11580-120F5	12.84	6.85	1.54	2.40	1.37	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	15.31	8.60	1.05	3.15	1.47	0.00	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	6.62	10.46	1.05	1.39	1.74	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	12.13	13.91	1.94	2.91	1.29	0.00	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	12.08	9.84	1.49	1.34	1.64	0.00	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	20.99	15.71	1.15	3.33	2.64	0.23	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	20.80	13.91	1.63	3.51	2.00	0.25	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	16.27	15.13	1.37	3.87	1.71	0.00	0.23
Basophils, donor1	12241-129G9	11.77	7.85	0.00	0.78	1.57	0.00	0.26
Basophils, donor2	12242-129H1	12.63	5.41	0.72	1.08	1.80	0.00	0.00
Basophils, donor3	12243-129H2	16.46	11.17	0.59	2.06	1.47	0.00	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	15.31	20.91	1.08	1.08	2.16	0.00	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	10.06	10.52	0.91	2.29	2.29	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	0.00	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	9.41	10.67	0.00	0.63	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	10.19	10.19	0.21	1.87	2.29	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	8.75	9.21	0.92	0.92	1.61	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	12.96	11.52	0.36	0.90	1.44	0.00	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	4.74	12.88	2.27	0.52	0.72	0.21	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	5.36	4.43	1.63	0.70	1.63	0.70	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	17.27	15.99	1.60	1.92	0.64	0.00	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	20.68	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	15.78	10.14	0.56	0.56	1.69	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	24.13	14.85	0.56	2.04	2.41	0.37	0.37
CD14+ Monocytes, donor3	11381-118B4	23.27	13.61	0.66	1.54	3.51	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	13.87	30.57	7.36	1.42	1.42	0.57	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	19.33	20.85	4.55	2.27	2.65	0.38	2.27
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	21.37	29.26	5.26	1.97	0.33	1.31	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	20.38	15.47	2.02	2.60	2.31	0.29	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	14.18	7.54	1.21	0.60	2.11	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	17.77	11.37	0.95	1.66	3.79	0.47	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	11.55	12.39	1.00	0.84	1.34	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	9.11	12.42	0.28	0.83	1.93	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	10.41	11.16	0.25	0.74	1.74	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	6.85	9.20	0.20	0.98	1.37	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	10.15	6.59	0.18	0.53	0.53	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	7.62	6.53	0.65	0.65	0.65	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	8.43	12.17	0.23	0.23	0.94	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	12.14	9.50	0.53	1.58	2.11	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	13.31	11.09	0.00	0.00	3.33	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	14.58	13.24	0.59	1.04	1.64	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	11.37	8.78	1.20	0.80	2.59	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	8.33	6.87	0.00	0.42	1.46	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	8.24	8.92	0.23	1.14	0.92	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	7.69	5.43	0.23	0.00	0.68	0.23	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	7.86	7.86	0.00	0.44	0.87	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	8.34	12.91	1.88	0.81	1.08	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	15.35	10.82	0.70	1.40	0.87	0.17	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	15.57	7.15	1.26	2.52	4.21	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	5.88	7.35	0.00	0.37	0.37	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	5.64	6.69	0.00	0.00	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	6.58	9.65	0.00	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	9.94	9.94	0.17	0.52	0.87	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	10.04	10.04	1.12	0.37	1.49	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	9.92	6.04	1.08	0.00	0.86	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.14	6.14	0.41	0.82	0.82	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	3.48	5.56	0.00	0.00	1.16	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	4.41	4.18	0.00	0.00	0.70	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	8.06	6.97	0.00	0.87	1.09	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	12.94	7.85	0.92	1.39	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	11.91	4.33	0.22	0.22	3.90	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	22.42	11.68	0.93	1.71	3.43	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	14.15	8.91	0.70	1.40	0.70	0.17	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	22.74	9.14	0.45	0.22	2.23	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	20.41	9.44	0.26	0.51	2.55	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	15.59	9.00	0.22	1.10	1.98	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	12.84	6.11	0.42	0.63	1.47	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	20.32	0.00	2.03	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	21.02	13.56	0.00	1.36	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	15.53	11.39	1.04	3.11	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	14.39	20.26	1.07	1.07	1.07	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	18.23	18.76	2.14	1.07	1.61	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	20.36	11.23	2.11	0.70	2.81	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	21.18	13.33	0.00	2.35	1.57	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	23.73	15.82	0.00	1.32	2.64	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	13.97	12.33	0.00	0.82	4.11	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	21.04	7.98	0.00	1.45	2.18	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	21.20	15.65	1.01	3.03	2.52	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	17.78	18.18	2.02	0.81	4.44	0.00	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	14.38	6.79	0.80	0.00	3.20	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	16.06	1.00	0.00	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	13.48	10.67	1.69	0.00	1.12	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	10.15	6.76	1.50	1.13	1.50	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	13.75	11.50	1.13	1.35	0.90	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	48.56	15.00	1.43	3.57	3.93	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	41.64	15.31	0.61	3.67	2.45	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	30.80	18.30	0.30	1.52	2.74	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	16.34	5.62	0.00	1.53	2.04	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	18.87	9.43	0.67	2.25	1.57	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	19.26	8.05	1.15	2.01	1.15	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	25.13	18.49	0.47	0.95	3.32	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	24.58	17.56	1.40	2.11	2.11	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	16.48	3.30	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	15.61	6.50	0.29	1.88	1.16	0.29	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	21.35	6.95	1.02	2.71	2.37	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	20.31	6.77	0.64	1.77	2.26	0.32	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	21.07	10.76	0.00	1.34	1.34	0.00	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	14.67	9.43	0.70	1.40	1.05	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	18.92	7.48	0.00	0.88	2.20	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	18.97	7.17	0.84	0.42	0.84	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	23.06	7.69	1.04	3.32	1.25	0.42	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	22.39	5.35	1.34	4.01	2.34	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	29.91	16.86	0.00	2.99	3.81	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	30.55	20.90	3.22	0.54	3.22	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	16.14	12.55	0.00	1.79	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	22.07	7.23	0.56	0.93	1.67	0.56	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	17.33	8.45	1.30	2.17	1.30	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	22.49	9.46	2.10	1.26	2.31	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	20.22	12.13	0.51	0.51	1.01	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	27.73	13.86	1.30	1.30	2.17	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	21.35	5.67	0.87	1.74	2.61	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	22.27	11.38	0.49	1.48	1.48	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	18.46	6.46	0.00	0.92	2.77	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	16.75	11.17	1.40	2.79	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	25.75	10.25	0.55	1.38	3.60	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	26.50	14.48	2.21	0.74	1.96	0.00	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	29.26	16.94	0.00	1.54	6.16	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	29.01	20.41	1.07	1.43	2.15	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	15.23	13.85	1.38	5.54	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	26.85	17.35	1.96	0.98	2.29	0.33	0.33
CD8+ T Cells, donor2	11307-117C2	22.53	22.53	1.50	1.13	2.25	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	38.63	22.72	1.51	1.77	5.81	1.01	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	11.70	17.89	0.46	0.46	4.36	0.46	2.29
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.26	19.17	0.72	0.96	3.59	0.72	2.16
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	9.30	21.89	0.55	0.55	4.10	1.09	1.64
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	11.11	13.21	2.40	0.00	3.00	0.00	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	12.96	19.92	1.44	0.96	5.52	0.24	2.40
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	11.37	25.24	1.59	0.91	5.00	0.45	3.64
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	10.00	25.42	1.52	0.00	3.48	0.65	1.09
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	12.11	28.16	1.05	0.26	3.42	0.26	2.37
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	10.55	27.91	1.17	0.23	3.99	0.00	2.58
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	13.89	26.26	0.91	0.91	4.83	0.60	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	10.46	31.08	1.45	1.45	3.78	0.87	1.74
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	11.72	23.18	2.40	1.33	6.66	0.53	2.40
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	12.26	30.64	2.19	0.44	6.13	0.44	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	9.56	30.97	2.28	0.91	4.55	0.00	2.28
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	13.43	36.55	1.49	0.00	6.71	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	11.52	16.21	2.88	1.08	4.32	0.00	4.32
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	12.95	18.70	2.30	0.58	5.75	0.29	4.32
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	14.61	24.04	3.54	1.65	2.12	0.94	3.77
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	13.63	21.23	1.27	0.00	5.39	0.95	3.49
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	13.84	25.84	1.85	0.00	5.84	0.31	2.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	11.54	22.76	1.60	0.00	4.49	0.00	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	8.80	25.63	1.53	0.38	7.65	0.00	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	13.40	24.43	0.39	0.00	5.12	1.97	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	12.10	21.94	2.27	0.00	8.32	0.76	4.54
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	12.85	39.34	0.80	0.80	4.82	0.80	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	21.68	55.95	4.20	0.00	7.69	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	15.03	48.08	3.01	1.00	11.02	0.00	5.01
Cardiac Myocyte, donor1	11525-119I4	3.66	0.00	0.00	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	13.83	7.41	0.49	1.98	1.98	0.00	0.99
Cardiac Myocyte, donor3	11686-122I3	12.63	6.10	0.21	0.84	1.16	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	15.25	9.71	1.73	1.04	2.08	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	9.24	7.46	1.42	0.36	1.78	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	13.88	10.92	0.34	2.96	2.16	0.46	0.00
Chondrocyte - re diff, donor2	11339-117F7	13.43	5.37	0.00	0.00	0.90	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	13.75	8.49	1.21	0.40	0.00	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	10.67	5.62	1.72	1.49	0.80	0.23	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	11.33	4.28	1.07	2.57	2.14	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	12.74	7.35	1.15	1.95	1.50	0.18	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	30.81	17.97	28.79	4.49	2.75	1.01	1.10
Corneal Epithelial Cells, donor1	11526-119I5	14.71	12.08	1.10	1.10	2.63	0.22	0.44
Corneal Epithelial Cells, donor2	11606-120I4	18.20	28.44	3.41	1.14	4.55	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	13.29	18.41	1.28	0.51	1.28	0.00	1.53
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	16.67	10.73	1.98	2.97	1.49	0.00	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	12.93	8.83	2.52	1.26	1.26	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	12.85	7.99	0.65	2.27	1.62	0.11	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	27.67	10.93	0.34	2.05	1.71	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	21.54	5.88	0.00	2.61	1.31	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	23.71	9.68	1.45	0.97	2.42	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	7.67	9.17	1.33	2.17	0.83	0.17	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	6.45	8.80	0.00	0.59	1.17	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	7.64	10.46	0.57	0.57	1.70	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	12.19	16.91	1.18	1.18	1.97	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	14.25	13.09	1.45	2.91	1.45	0.00	0.87
Endothelial Cells - Artery, donor2	11341-117F9	17.88	11.53	0.94	2.35	1.65	0.47	0.47
Endothelial Cells - Artery, donor3	11413-118E9	11.22	9.64	1.05	1.40	2.10	0.00	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	9.09	11.08	0.44	0.66	2.22	0.22	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	16.13	13.69	1.22	0.30	2.74	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	12.69	15.50	1.13	0.56	1.69	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	16.64	15.15	1.78	0.89	2.08	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	7.81	10.93	0.52	1.04	2.60	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	17.44	15.45	1.28	2.69	1.70	0.14	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	12.00	11.20	1.60	1.60	1.20	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	9.43	12.05	1.05	0.52	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	13.05	10.31	1.12	1.62	1.99	0.25	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	14.12	8.04	0.65	2.39	1.09	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	11.72	8.79	0.73	1.71	1.83	0.00	0.24
Endothelial Cells - Vein, donor1	11267-116G7	5.69	5.69	0.00	1.14	2.28	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	12.57	11.18	0.70	0.70	4.19	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	10.52	9.26	0.94	1.10	1.73	0.00	0.16
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	34.66	29.70	0.00	3.30	8.25	0.00	0.00
Eosinophils, donor3	12246-129H5	21.40	24.97	0.00	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	12.46	8.06	1.22	0.98	1.71	0.00	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	31.20	2.08	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	32.54	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	10.26	6.98	0.82	1.23	1.64	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.55	5.26	0.99	0.88	1.20	0.66	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	6.07	5.96	0.98	0.87	1.63	0.22	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	8.97	6.06	1.09	1.09	1.21	0.36	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	6.55	3.82	0.55	1.23	1.09	0.00	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	12.23	8.75	2.21	2.43	2.11	0.42	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	26.88	7.90	1.84	1.32	2.90	0.53	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	14.62	10.63	1.00	1.00	1.66	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	9.07	4.08	0.45	0.91	1.36	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	11.37	4.55	3.03	1.52	2.27	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	14.35	8.36	0.95	2.21	2.21	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	13.03	9.09	1.21	0.91	2.12	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	13.83	5.46	1.27	2.92	0.89	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	10.91	5.61	0.30	1.52	0.91	0.00	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	15.27	10.72	0.40	0.40	2.28	0.40	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.94	3.88	0.00	0.43	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	4.39	1.46	1.46	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	23.29	9.46	0.92	2.31	2.31	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	21.20	21.54	1.36	2.88	2.37	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	11.97	7.04	1.64	1.64	3.05	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	6.60	5.66	0.00	0.00	1.89	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	10.15	9.07	1.09	1.81	2.06	0.24	0.12
Fibroblast - Dermal, donor4	11450-119A1	7.12	6.56	0.45	2.03	1.02	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	7.33	6.80	0.35	1.22	1.40	0.00	0.17
Fibroblast - Dermal, donor6	11458-119A9	9.26	5.36	0.65	1.30	1.95	0.16	0.32
Fibroblast - Gingival, donor1	11237-116D4	13.74	8.33	1.04	1.46	1.04	0.00	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	14.67	8.12	1.57	2.62	4.72	0.79	0.79
Fibroblast - Gingival, donor2	11318-117D4	11.20	5.40	0.66	1.45	0.79	0.00	0.00
Fibroblast - Gingival, donor3	11394-118C8	19.14	9.86	1.55	3.00	2.61	0.00	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	18.70	6.23	3.12	1.04	2.08	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	14.98	15.86	2.29	2.11	1.06	0.35	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	13.10	6.86	1.09	1.71	1.40	0.00	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	10.95	6.09	0.95	0.81	2.30	0.41	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	50.46	28.58	2.47	10.94	5.65	1.06	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	11.99	7.75	0.58	2.92	1.32	0.15	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	11.73	7.09	0.41	1.36	1.91	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	10.20	11.63	1.43	1.65	1.54	0.00	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	24.51	10.71	3.23	2.79	3.23	0.73	0.44
Fibroblast - Lung, donor1	11270-116H1	10.87	10.87	0.00	2.72	4.08	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	22.38	7.46	0.00	2.98	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	17.52	12.87	1.06	4.43	1.69	0.00	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	19.16	21.66	1.67	1.67	3.33	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	5.59	0.00	2.80	0.00	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	11.47	8.68	0.00	0.56	1.68	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	15.02	7.71	1.22	0.81	3.65	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	7.99	11.98	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	10.47	9.31	0.39	2.52	0.78	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	15.17	10.31	0.76	3.03	1.21	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	10.40	9.79	1.53	1.53	0.92	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	11.07	6.87	1.14	2.29	2.29	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	11.34	6.75	0.81	0.54	2.16	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	18.79	15.54	3.94	2.20	2.78	0.23	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	8.18	4.64	0.44	1.11	1.11	0.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	19.91	14.63	0.61	1.63	3.66	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.70	9.35	0.00	1.34	2.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	14.23	7.12	0.79	1.98	2.37	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	10.91	4.76	0.99	1.19	0.99	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	10.30	9.41	1.24	0.89	1.95	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	14.98	5.32	0.59	0.39	0.79	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	17.45	5.72	0.60	3.31	1.20	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	11.87	5.83	0.54	0.97	2.59	0.11	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	8.60	4.05	1.01	1.01	0.76	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	10.99	7.88	1.31	0.49	1.31	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	20.65	5.61	0.20	1.80	2.01	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	11.35	5.42	0.60	0.80	1.31	0.20	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	8.76	2.72	0.91	0.91	1.51	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	15.16	10.11	1.08	0.91	1.33	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	15.73	8.38	0.85	0.85	1.71	0.34	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.36	5.58	0.66	1.31	1.64	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	7.88	5.22	0.75	0.32	0.53	0.11	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	8.27	5.74	0.67	1.69	1.01	0.00	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	6.59	3.92	0.47	0.31	0.94	0.16	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.89	33.99	3.49	5.23	9.59	0.00	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	10.92	13.87	1.56	1.04	2.77	0.17	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	8.33	14.31	0.78	1.82	3.64	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	14.31	10.22	1.02	1.28	3.07	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	25.26	13.01	6.12	2.30	7.66	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	13.40	15.31	11.49	1.28	2.55	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	19.40	10.84	2.85	2.85	0.86	0.29	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	29.23	22.61	9.93	4.14	2.48	1.38	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	21.01	21.46	9.82	4.57	2.05	0.46	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	24.96	17.44	4.56	4.36	1.59	1.19	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	25.64	36.48	9.78	5.29	2.91	0.79	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	22.50	26.42	11.74	4.57	2.61	1.63	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	14.59	12.82	3.98	1.33	0.88	1.33	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	20.21	22.33	4.66	3.82	1.70	0.42	1.70
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	21.18	22.90	3.57	3.20	2.22	0.86	1.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	18.80	12.09	2.15	6.18	2.42	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	14.25	21.93	1.49	2.85	1.61	0.00	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	16.33	26.58	3.05	3.18	1.38	0.42	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	12.40	22.57	2.24	1.22	2.24	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	19.62	16.89	2.51	3.42	3.42	0.23	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	16.82	23.42	1.87	2.24	2.99	0.12	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	21.64	28.63	2.40	1.97	2.62	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	18.91	17.14	2.95	1.48	1.48	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	25.12	23.53	3.18	2.07	3.18	0.48	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	21.90	27.26	3.13	4.02	3.80	0.22	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	20.36	16.53	1.81	3.02	1.61	0.40	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	21.21	24.09	3.05	4.41	3.05	0.85	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	19.24	31.12	3.72	2.22	3.10	0.27	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	18.94	16.44	3.12	1.35	2.39	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	14.86	12.13	1.54	0.68	2.73	0.17	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	23.57	18.81	3.54	3.76	2.88	0.33	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	18.05	26.12	3.08	2.41	2.25	0.42	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.97	14.70	2.65	1.43	2.65	0.20	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	19.60	17.54	2.48	2.06	2.27	0.21	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	26.06	20.29	2.88	3.23	2.08	0.23	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	21.01	24.51	2.67	3.00	1.83	0.33	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	20.28	13.45	2.20	2.65	1.98	0.22	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	24.48	20.05	2.34	3.32	2.34	0.12	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	23.99	20.59	3.89	2.76	2.76	0.65	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	21.49	14.43	4.81	1.28	2.25	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	23.31	17.43	1.90	3.22	2.84	0.28	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	18.35	20.40	1.58	3.48	2.85	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	22.81	12.47	3.04	2.74	3.04	0.61	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	23.94	16.94	3.03	2.40	1.78	0.31	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	19.10	18.44	1.76	1.98	2.20	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	24.41	16.83	3.65	3.93	2.81	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	23.70	17.59	2.13	2.78	2.78	0.56	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	22.19	20.06	1.60	1.34	2.67	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	20.81	12.85	2.75	2.75	1.84	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	19.69	16.45	2.59	2.59	2.72	0.26	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	24.13	27.11	4.88	2.98	3.80	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	24.89	12.17	1.84	2.95	3.50	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	26.10	14.26	2.41	2.85	3.07	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	46.61	49.59	1.98	0.99	8.93	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	15.43	10.68	1.06	2.90	2.90	0.00	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	23.20	10.49	1.82	2.62	1.82	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	35.33	33.29	6.35	4.07	5.08	0.25	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	13.74	12.54	3.98	1.79	1.00	0.80	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	20.34	20.34	3.70	3.85	2.62	0.00	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	22.91	20.87	4.30	4.50	2.86	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	13.14	15.33	6.26	1.56	2.50	0.31	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	10.17	10.45	3.39	1.70	2.54	0.28	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	8.76	7.38	3.69	1.84	1.38	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	2.47	4.95	14.85	2.47	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	17.02	14.70	7.74	2.71	1.55	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	25.67	19.25	3.21	1.60	4.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	24.34	12.17	6.96	3.48	5.22	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	16.92	11.07	6.18	2.60	2.93	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	16.06	12.77	2.47	2.88	2.47	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	19.99	13.33	6.66	0.00	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	13.70	16.22	3.64	2.24	1.40	0.56	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	15.69	17.32	4.25	2.61	0.98	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	9.23	11.74	1.68	2.52	0.84	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	18.77	20.04	4.77	3.18	2.86	0.32	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	15.28	19.70	4.76	3.74	0.68	1.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	12.53	20.88	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	18.33	26.34	1.15	2.29	5.73	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	14.21	15.69	2.07	1.78	2.37	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	22.02	25.41	5.08	1.69	3.39	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	18.23	19.05	2.07	3.31	2.49	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	19.10	21.63	5.52	2.07	2.99	0.23	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	10.54	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	16.91	10.38	4.61	2.31	0.77	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	12.06	14.99	3.91	0.65	1.63	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	14.71	16.05	4.01	0.67	2.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	24.66	16.95	4.62	3.85	1.16	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	33.55	22.59	6.50	3.08	2.05	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	27.33	42.24	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	16.99	15.57	1.89	0.94	0.94	1.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	21.73	19.31	1.21	3.62	1.81	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	26.96	18.82	3.56	2.54	3.56	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	21.94	17.15	5.18	1.60	1.60	0.00	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	24.17	20.72	1.48	0.49	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	18.89	21.25	5.90	3.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	22.17	15.17	4.08	0.00	2.33	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	16.24	22.82	2.19	3.07	2.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	14.41	19.50	3.39	0.85	1.70	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	14.33	17.91	2.39	1.79	1.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	18.92	11.16	1.46	0.49	2.91	0.00	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	3.42	3.42	0.00	0.00	2.28	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	14.14	9.15	0.83	1.66	1.25	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	7.87	10.12	0.00	0.00	3.37	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	8.56	2.54	0.95	0.32	0.32	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	5.01	2.92	0.84	0.84	0.84	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	10.56	5.45	1.86	3.02	1.86	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	11.14	4.39	0.84	0.34	1.52	0.00	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	8.19	4.55	1.37	0.68	1.37	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	8.74	5.14	0.87	2.08	0.66	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	10.75	4.30	1.07	1.29	1.29	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	7.53	4.31	2.37	0.86	1.72	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	8.34	4.23	1.25	1.87	1.25	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	8.41	4.12	0.69	0.86	1.03	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	8.01	3.20	0.64	0.64	1.60	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	19.59	24.06	2.80	3.92	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	15.58	7.79	2.16	1.73	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	2.64	2.64	0.00	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	13.76	5.64	1.76	0.35	2.47	0.00	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	11.62	2.91	0.00	0.73	1.45	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	7.69	4.02	0.17	0.52	0.52	0.17	0.00
Hepatocyte, donor1	11523-119I2	14.53	10.90	3.63	0.00	1.21	1.21	0.00
Hepatocyte, donor2	11603-120I1	31.24	10.77	2.15	4.31	2.15	0.00	1.08
Hepatocyte, donor3	11684-122I1	19.63	7.98	0.61	1.84	3.07	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	10.44	15.01	1.31	2.61	1.31	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	18.35	17.30	2.97	1.40	2.80	0.35	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	8.10	5.49	0.27	0.82	0.69	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	3.18	6.37	0.00	0.00	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	11.08	4.15	0.00	1.38	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	5.01	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	23.74	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	12.81	0.00	0.00	10.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	6.50	4.87	0.00	3.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	6.67	1.67	0.00	0.00	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	7.26	3.63	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	10.59	3.97	1.32	1.32	2.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	7.76	2.22	1.11	1.11	2.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	5.24	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	9.45	7.56	0.00	1.26	1.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	4.64	0.00	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	12.92	7.11	0.00	0.65	2.58	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	6.44	8.05	0.00	0.00	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	8.96	7.33	0.00	1.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	7.98	5.04	0.42	1.26	1.26	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.04	9.64	0.00	0.80	3.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	8.31	5.54	0.92	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	9.91	4.25	0.94	0.94	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	4.53	8.16	0.91	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	7.53	4.30	0.00	0.00	2.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	10.16	5.08	1.27	0.00	5.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	8.29	7.65	2.55	0.64	1.28	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	3.65	0.00	0.00	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	10.00	5.71	0.71	0.71	0.71	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	11.42	6.48	1.54	1.23	1.85	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	12.29	1.76	0.00	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	3.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	8.34	7.65	1.39	1.39	2.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	6.64	0.00	8.85	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	3.24	0.00	6.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	19.18	8.72	1.74	1.74	2.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	11.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	10.45	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	13.87	10.67	0.00	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	1.39	1.39	1.39	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	5.70	0.00	2.85	5.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	8.28	5.52	0.00	1.84	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	3.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	12.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	10.57	10.57	0.00	1.06	2.11	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	15.99	22.77	2.04	1.80	2.45	0.24	0.16
Keratinocyte - epidermal, donor2	11349-117G8	7.03	10.54	1.76	0.59	0.59	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	15.90	14.58	0.66	2.08	2.56	0.09	0.47
Keratinocyte - oral, donor1	11251-116E9	21.45	23.61	1.48	3.18	2.04	0.00	0.23
Keratocytes, donor1	11527-119I6	17.88	19.25	1.72	0.34	2.75	0.00	0.69
Keratocytes, donor2	11607-120I5	15.23	4.69	0.00	2.34	3.52	0.00	0.00
Keratocytes, donor3	11688-122I5	16.20	11.26	0.59	2.77	2.37	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	19.78	2.20	0.00	2.20	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	11.87	5.39	0.00	2.16	2.16	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	16.49	15.57	1.73	2.42	0.92	0.12	0.35
Lens Epithelial Cells, donor3	11690-122I7	12.41	5.85	0.71	1.51	1.41	0.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	12.81	12.81	0.83	0.95	1.90	0.12	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.26	8.93	1.40	1.67	0.84	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	12.44	12.75	1.57	1.89	1.10	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	9.14	5.38	1.08	0.54	2.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.92	11.66	0.32	2.52	0.95	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	9.60	9.49	0.32	1.51	0.65	0.22	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.98	10.67	0.41	0.41	0.82	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	11.88	11.38	0.25	1.77	1.01	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	10.70	13.23	1.55	1.27	0.84	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.89	14.63	0.79	1.19	3.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.11	10.66	0.97	1.36	1.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.81	9.07	1.48	1.30	1.48	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	10.10	12.19	0.70	1.05	2.09	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	14.31	11.93	0.48	2.15	1.67	0.48	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	12.09	13.46	1.10	1.51	1.24	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	11.09	11.09	0.00	0.92	1.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	13.40	11.22	0.00	1.87	1.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	11.53	10.80	1.28	1.28	1.46	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	11.19	7.24	0.33	0.99	0.99	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	13.18	9.37	0.29	1.76	1.17	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	12.45	10.21	0.50	1.24	1.49	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	9.21	8.24	0.00	0.00	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.96	15.35	0.54	1.08	1.62	0.27	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	10.45	13.02	1.21	2.42	0.91	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.26	10.37	0.00	2.07	2.59	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	10.68	9.84	0.42	1.05	2.51	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	13.68	12.78	1.05	2.26	0.75	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.25	9.63	1.38	0.00	2.06	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	10.35	14.11	0.75	1.51	0.94	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	11.56	11.35	0.42	2.01	1.17	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	10.66	11.15	0.97	0.48	2.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	9.26	11.58	0.33	2.32	2.98	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	12.64	12.39	0.50	2.11	0.99	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	7.03	13.70	0.00	1.11	1.48	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	9.88	12.35	0.74	1.98	0.49	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	10.31	11.14	0.82	1.92	1.65	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	9.97	12.22	0.32	1.29	1.29	0.00	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	11.56	13.39	0.61	0.91	1.83	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	11.20	13.72	0.84	1.68	0.84	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	8.89	10.31	0.36	1.78	2.13	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	12.60	17.45	0.48	0.48	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	12.45	11.98	0.62	1.56	1.56	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	11.82	9.31	0.36	1.79	2.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	16.33	17.31	0.33	1.63	1.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	13.18	13.89	0.47	2.12	1.88	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	12.25	15.72	0.62	1.11	1.49	0.12	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	12.29	15.37	0.51	1.79	3.07	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	10.74	9.55	1.79	0.30	2.39	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	15.86	15.86	0.00	4.53	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.88	11.51	0.77	1.53	0.77	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	20.78	11.13	3.71	0.74	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	20.31	13.96	2.54	2.54	2.12	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	21.80	7.74	0.70	3.52	2.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	15.88	9.34	0.00	1.87	4.67	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	17.52	5.15	1.55	3.61	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	22.60	10.71	0.00	3.57	2.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	19.23	10.40	0.90	2.71	1.58	0.23	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	15.41	14.25	1.74	1.74	1.45	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	16.21	11.70	1.35	2.25	3.15	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	22.63	13.68	2.17	3.12	1.90	0.14	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	21.57	14.89	2.57	5.14	2.05	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	23.64	8.82	2.47	3.88	1.41	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	15.33	6.66	0.00	1.33	4.66	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	21.90	12.73	2.55	3.57	5.60	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	20.54	8.00	1.33	3.47	3.74	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	20.03	10.58	2.46	2.08	2.46	0.00	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	20.86	12.27	3.07	3.07	2.45	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	22.02	11.42	3.26	3.26	2.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	18.33	12.91	2.08	3.12	2.71	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	13.73	12.05	2.80	1.96	2.80	0.00	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	26.79	12.36	2.06	6.18	1.03	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	21.19	9.87	3.19	2.90	3.19	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	16.14	12.26	0.90	1.20	2.69	0.00	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	15.49	8.30	1.11	4.43	1.11	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	27.57	13.08	1.41	1.77	3.18	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	18.44	10.69	2.58	3.32	1.84	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	16.12	14.97	2.30	3.45	2.30	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	27.63	12.66	1.54	4.22	2.30	0.38	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	16.98	8.49	3.96	5.10	2.83	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	27.90	5.74	5.74	2.46	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	21.24	13.56	1.81	3.62	2.26	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	15.08	13.64	0.72	1.44	3.59	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	21.66	7.47	2.99	4.48	4.48	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	21.18	21.92	2.23	5.95	1.49	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	18.52	7.32	0.86	2.15	1.29	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.99	11.99	3.43	2.57	2.57	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	17.99	11.99	1.33	4.00	2.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	18.10	15.69	2.41	1.81	4.22	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	23.46	11.38	1.42	3.55	4.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	19.94	10.66	3.78	2.06	2.41	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	16.10	9.66	3.22	3.76	2.68	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	20.87	14.14	2.02	2.69	1.35	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	28.52	12.59	2.22	3.70	2.22	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	12.79	11.63	2.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	17.98	11.64	5.29	5.29	5.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	21.61	12.80	1.60	3.60	2.80	0.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	22.53	10.18	1.45	2.18	2.91	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	29.13	10.73	2.30	3.83	3.83	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	25.65	13.81	1.97	2.96	1.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	31.99	12.23	3.76	2.82	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	26.15	14.58	1.51	3.02	2.01	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	34.25	12.62	4.51	3.60	1.80	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	20.65	6.88	0.00	3.44	3.44	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	23.60	11.58	2.23	2.67	1.34	0.45	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	26.98	8.99	2.35	1.56	2.74	0.00	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	32.33	11.22	2.64	5.28	3.30	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	29.06	11.94	1.04	4.15	3.63	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	24.94	17.50	2.19	2.19	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	16.77	10.62	1.68	2.24	1.68	0.00	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	23.41	8.39	3.53	3.09	3.09	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	23.91	15.43	1.54	5.40	3.09	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	14.68	7.60	1.01	2.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	26.43	10.57	1.92	1.92	2.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	19.48	13.52	1.99	3.18	1.59	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	14.58	9.72	3.04	1.22	3.04	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	11.76	10.38	2.08	0.69	6.23	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	27.36	13.30	3.04	4.18	2.66	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	12.39	8.78	2.07	2.58	3.10	0.00	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	22.37	10.88	3.02	7.86	6.05	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	22.50	12.68	3.17	2.22	0.32	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	21.86	9.06	2.67	1.07	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	19.54	9.77	1.15	0.00	2.30	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	22.63	15.94	3.60	3.60	2.06	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	15.56	19.81	2.83	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	13.62	11.92	3.97	3.97	3.40	0.00	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	27.87	14.14	3.33	3.33	3.74	0.00	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	22.71	10.96	0.78	3.92	2.35	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	17.54	7.10	3.76	0.84	2.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	23.23	14.40	1.86	4.18	2.79	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	12.04	4.68	2.68	0.67	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	16.04	15.50	3.21	2.14	3.21	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	20.20	10.51	2.02	3.64	1.62	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	13.77	9.18	2.75	0.00	1.84	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	19.56	6.22	2.67	1.78	4.45	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	23.36	17.67	1.71	0.00	3.99	0.57	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	13.04	15.34	1.53	2.30	1.53	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	21.89	10.94	3.28	3.28	4.38	0.00	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	21.83	13.81	2.67	2.23	1.78	0.45	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	16.64	16.38	4.16	1.04	2.34	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	23.21	7.29	1.33	1.99	3.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	16.63	4.16	6.24	4.16	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	10.26	10.03	2.05	0.46	1.37	0.23	0.68
Macrophage - monocyte derived, donor2	11313-117C8	7.52	5.14	0.73	0.92	0.92	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	11.14	13.50	1.57	1.05	1.18	0.13	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	10.09	6.37	0.53	0.53	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	8.87	7.92	0.63	0.16	2.06	0.16	0.32
Mallassez-derived cells, donor3	11930-125I4	7.51	9.73	0.56	0.28	1.39	0.00	0.28
Mammary Epithelial Cell, donor1	11273-116H4	14.35	9.27	0.50	1.79	1.99	0.10	0.30
Mammary Epithelial Cell, donor2	11350-117G9	11.58	9.84	0.58	0.87	3.19	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	9.98	8.73	1.00	2.24	1.50	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	1.36	4.75	0.00	0.00	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	13.09	11.03	3.68	1.41	2.27	0.32	0.54
Mast cell, donor2	11565-120D8	22.88	21.99	10.40	2.08	1.19	0.89	0.00
Mast cell, donor3	11566-120D9	22.51	19.81	8.78	1.58	3.83	0.90	0.45
Mast cell, donor4	11567-120E1	19.32	25.35	11.17	2.30	1.77	1.24	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	17.74	10.98	2.33	1.89	1.44	0.11	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	16.93	8.76	4.67	2.33	0.58	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	13.42	10.55	4.36	1.49	1.84	0.69	0.34
Mast cell, expanded, donor8	11941-126A6	25.11	14.23	5.02	3.51	2.01	0.50	0.17
Melanocyte - dark, donor1	11502-119F8	11.14	13.83	0.30	0.99	1.49	0.10	0.10
Melanocyte - dark, donor2	11582-120F7	10.04	7.96	0.00	0.69	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	17.24	9.71	1.67	1.74	2.54	0.22	0.22
Melanocyte - light, donor1	11274-116H5	15.98	13.87	4.94	1.41	2.12	0.24	0.71
Melanocyte - light, donor2	11351-117H1	11.60	9.55	6.14	1.36	0.68	0.68	0.68
Melanocyte - light, donor3	11423-118G1	12.14	8.67	3.47	2.60	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	11.97	6.98	1.25	1.35	1.15	0.10	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	11.56	8.88	0.27	1.34	2.15	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	20.62	18.21	2.14	2.41	3.48	0.27	0.00
Meningeal Cells, donor1	11493-119E8	10.92	7.94	0.50	1.24	1.86	0.25	0.12
Meningeal Cells, donor2	11573-120E7	16.73	8.80	0.88	1.32	1.76	0.44	0.44
Meningeal Cells, donor3	11654-122E7	9.54	6.76	0.24	1.22	2.28	0.08	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	7.41	8.55	0.29	2.57	1.43	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	8.15	4.03	0.70	0.81	1.11	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	7.88	1.31	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	7.85	1.31	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	8.61	5.02	0.00	0.72	2.15	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	13.13	6.14	1.48	1.27	1.91	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	6.53	6.53	1.51	1.51	1.51	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	11.21	2.64	0.66	0.66	3.08	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.84	5.84	0.73	2.19	1.46	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	10.64	2.86	0.82	1.84	1.02	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	10.25	6.23	0.69	0.14	1.39	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	14.13	4.09	0.00	0.74	1.86	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	14.34	9.34	0.79	1.18	1.18	0.13	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	13.95	5.64	0.59	1.78	0.59	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	4.67	7.01	0.00	4.67	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	9.61	1.28	0.64	0.64	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	6.38	5.67	0.00	1.42	1.77	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	12.20	7.51	0.63	1.88	0.94	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	5.81	6.53	0.73	0.73	2.90	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	13.52	6.10	2.39	0.80	1.06	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	11.51	8.01	1.50	1.50	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	12.79	6.21	0.65	2.02	1.16	0.14	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	12.15	14.85	2.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	11.57	14.53	1.23	0.49	1.72	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	11.48	9.42	0.88	0.88	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	20.74	0.00	6.91	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	4.65	10.23	0.93	0.93	0.93	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	9.75	8.30	0.83	1.66	1.24	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	6.95	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	12.51	12.76	1.75	1.00	2.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	13.03	10.24	1.40	2.79	0.93	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	12.60	15.24	0.61	2.24	1.42	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	13.46	9.11	1.98	1.98	0.79	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	6.19	14.16	0.00	0.00	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	10.64	11.02	1.14	1.52	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	2.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	6.58	9.76	1.49	0.85	0.64	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	7.37	1.84	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	6.86	8.94	0.60	0.60	1.79	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	15.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	6.77	7.03	0.50	1.25	0.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	6.42	11.41	0.00	2.38	0.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	4.42	5.53	3.32	1.11	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	4.60	4.37	0.23	0.00	1.15	0.00	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	6.94	6.10	0.63	0.84	1.05	0.21	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	3.06	4.69	0.41	1.02	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.65	5.58	0.43	0.21	0.64	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	5.78	7.11	0.22	0.89	2.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	2.85	4.38	0.22	0.44	0.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	10.65	3.55	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	6.63	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	2.45	2.99	0.00	0.82	1.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	4.71	4.71	0.00	0.59	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	5.45	0.00	1.09	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1.92	2.40	0.00	0.48	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	6.40	3.20	0.40	0.40	0.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	5.48	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	4.51	8.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	4.08	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	2.19	2.63	0.00	0.44	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	4.41	3.31	1.10	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	4.48	1.92	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	3.97	3.97	0.00	0.74	0.99	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.09	2.78	0.00	1.39	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	8.84	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	3.76	3.76	0.34	0.34	0.68	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	4.38	3.06	0.00	2.19	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	3.55	6.39	0.36	0.36	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	3.93	4.77	0.84	0.84	0.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	5.40	6.65	0.00	0.42	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	3.50	6.41	0.58	0.58	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	5.73	6.94	0.60	1.21	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	4.59	3.76	0.00	0.83	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	14.44	0.00	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	5.54	5.54	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	6.83	3.98	0.00	2.28	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	5.53	6.77	1.24	0.28	0.69	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	3.89	5.96	0.78	0.26	1.30	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.43	5.58	0.00	1.29	3.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	6.35	4.45	0.00	1.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	6.94	4.54	0.00	1.33	1.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	6.88	10.18	1.50	1.80	0.30	0.00	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.37	8.19	0.57	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	5.10	5.41	0.32	0.00	1.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.52	8.62	1.55	1.11	1.11	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	2.65	9.48	1.52	0.00	1.90	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	6.53	4.55	1.99	0.00	0.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	7.37	6.64	0.25	1.23	1.47	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	7.17	6.52	1.30	3.26	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	9.70	6.47	1.47	0.29	1.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	10.09	12.11	1.15	1.73	2.02	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	10.72	12.78	2.06	0.41	0.82	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	5.96	5.96	2.08	0.30	2.08	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	3.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	8.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	13.14	20.37	0.99	1.97	1.64	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	5.26	10.52	0.00	0.00	3.16	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	7.51	15.81	0.59	0.79	0.99	0.00	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.04	16.76	1.86	0.00	1.86	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	9.01	13.52	1.13	0.75	1.13	0.00	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	10.39	10.65	0.80	1.07	0.80	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	9.39	8.82	0.45	0.34	1.58	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	2.95	11.79	0.74	0.74	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	12.46	13.92	0.00	0.37	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	20.22	18.67	1.56	0.00	3.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	7.48	6.41	0.53	1.07	2.14	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	19.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	4.04	14.14	3.03	0.00	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	7.59	8.01	1.26	0.42	1.69	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	5.45	5.45	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	2.54	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	5.67	5.67	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	3.02	1.51	0.00	3.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	17.13	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	9.79	0.00	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	4.75	0.00	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	50.20	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	9.48	4.96	0.86	1.29	1.29	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	17.25	12.02	1.05	1.57	2.09	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	10.01	8.68	0.00	0.67	2.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	14.19	7.93	0.83	0.00	2.50	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	7.04	3.99	0.76	1.33	0.95	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	12.77	9.58	1.60	4.79	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.16	8.16	1.36	0.68	2.04	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	3.68	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	15.07	16.32	1.26	0.84	2.51	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	16.50	9.99	0.93	1.39	2.79	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	20.27	11.89	0.81	2.16	1.62	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	17.87	9.88	1.05	2.31	2.94	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	0.00	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	9.93	15.88	1.49	0.99	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.10	4.87	1.62	0.81	1.89	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	11.11	10.65	0.68	1.13	1.81	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	20.74	15.19	0.65	4.08	2.45	0.00	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	16.77	9.84	0.36	2.73	1.64	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	17.50	11.14	0.53	0.00	3.18	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	10.21	12.01	1.80	0.60	1.80	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	7.55	3.61	0.66	1.31	0.33	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	15.12	9.27	0.33	1.14	2.93	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	21.17	14.11	0.88	2.82	2.82	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.77	12.66	1.41	2.81	4.92	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	15.17	10.57	0.00	2.76	3.22	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	22.49	14.46	0.00	4.18	1.61	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	12.07	4.83	0.00	1.03	0.69	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	10.11	0.00	2.53	0.00	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	14.93	10.25	1.34	2.45	2.67	0.45	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	21.59	5.50	0.85	1.69	2.54	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	11.39	5.22	0.24	1.19	1.66	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	17.60	11.59	0.86	2.15	2.58	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.99	14.99	0.67	2.67	2.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	17.13	8.57	1.35	3.16	0.90	0.00	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.48	4.76	2.38	1.59	1.98	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	14.86	13.93	0.93	0.93	2.79	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	12.49	7.57	1.51	1.51	0.76	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	16.62	9.12	0.65	2.61	1.96	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	22.66	17.87	0.44	1.31	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	12.66	8.14	0.00	1.81	1.36	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	13.23	11.46	0.00	2.65	3.53	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	24.60	5.98	0.00	0.66	1.33	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	15.87	8.93	1.49	1.49	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	12.63	8.04	1.53	1.15	2.30	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	15.12	9.38	1.51	1.51	1.81	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	19.67	7.29	1.33	3.09	1.33	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	17.62	14.23	0.68	1.36	2.71	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	10.22	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.63	9.75	1.83	1.22	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	13.85	5.35	1.57	1.89	1.89	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	18.76	9.38	0.00	1.82	1.21	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	11.87	7.12	0.00	1.58	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	13.60	3.40	0.00	1.13	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	5.22	4.10	0.50	1.24	1.12	0.00	0.00
Myoblast, donor2	11322-117D8	9.78	6.33	1.34	2.11	1.34	0.19	0.19
Myoblast, donor3	11398-118D3	6.89	5.72	0.67	1.51	1.18	0.00	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	6.71	10.80	0.73	0.29	1.31	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	18.76	21.83	0.92	0.31	2.77	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	22.92	18.09	0.60	0.90	2.41	0.00	0.30
Natural Killer Cells, donor3	11387-118C1	26.69	21.53	1.84	3.68	2.39	0.55	0.55
Neural stem cells, donor1	11275-116H6	31.94	15.97	5.08	5.08	3.27	1.09	0.36
Neural stem cells, donor2	11352-117H2	28.88	28.88	5.78	3.85	7.70	0.00	0.00
Neurons, donor1	11494-119E9	23.90	15.93	5.69	5.69	10.24	0.00	0.00
Neurons, donor2	11574-120E8	42.05	19.15	4.84	5.28	2.20	0.66	0.88
Neurons, donor3	11655-122E8	15.62	13.98	7.40	5.76	1.64	0.82	1.64
Neutrophils, donor1	11233-116C9	36.19	25.98	1.86	5.57	5.57	0.00	0.00
Neutrophils, donor2	11314-117C9	37.69	17.39	0.00	8.70	11.60	0.00	0.00
Neutrophils, donor3	11390-118C4	39.70	37.26	1.22	2.44	4.28	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	19.59	12.82	1.07	2.26	1.31	0.12	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	19.54	9.12	0.33	2.28	1.30	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	12.43	5.62	0.40	1.80	1.80	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	15.69	5.92	0.28	2.48	0.83	0.28	0.14
Olfactory epithelial cells, donor2	11934-125I8	13.46	5.50	0.29	1.59	1.74	0.00	0.14
Olfactory epithelial cells, donor3	11935-125I9	13.96	4.65	0.79	1.48	0.79	0.00	0.11
Olfactory epithelial cells, donor4	11936-126A1	18.12	10.23	1.07	2.63	1.36	0.00	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	14.44	10.83	0.60	0.60	0.00	0.00	1.20
Osteoblast - differentiated, donor1	11276-116H7	13.61	7.66	1.91	0.85	1.28	0.21	0.43
Osteoblast - differentiated, donor2	11353-117H3	16.00	11.43	10.29	2.29	2.29	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	17.38	14.28	1.24	1.24	1.24	0.00	0.00
Osteoblast, donor1	11277-116H8	13.09	8.99	1.76	0.98	0.78	0.00	0.00
Osteoblast, donor2	11354-117H4	11.24	4.92	1.40	0.00	0.70	1.40	0.00
Osteoblast, donor3	11426-118G4	8.35	5.69	1.24	1.60	1.07	0.00	0.36
Pancreatic stromal cells, donor1	11249-116E7	12.47	13.39	1.85	1.18	1.68	0.08	0.34
Pericytes, donor1	11491-119E6	16.36	10.79	1.78	0.89	2.78	0.56	0.11
Pericytes, donor2	11571-120E5	23.09	11.32	1.36	4.75	3.62	0.23	0.00
Pericytes, donor3	11652-122E5	10.38	4.88	0.00	1.22	1.02	0.00	0.20
Perineurial Cells, donor1	11499-119F5	9.72	5.09	0.23	0.79	1.92	0.00	0.11
Perineurial Cells, donor2	11579-120F4	13.25	8.93	0.00	2.02	1.10	0.00	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	27.09	22.31	1.59	1.59	2.87	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	24.00	13.22	0.49	2.45	2.45	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	28.08	22.00	1.81	2.85	2.07	0.00	0.26
Placental Epithelial Cells, donor1	11278-116H9	9.09	8.13	0.72	0.24	0.96	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	17.74	9.98	4.44	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	15.90	9.62	1.37	2.36	1.37	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	13.92	3.16	0.32	1.27	0.32	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	8.44	3.19	1.13	0.56	1.69	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	6.13	2.35	0.00	0.65	0.39	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	12.83	8.11	0.68	1.35	1.13	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	10.55	8.74	1.39	1.07	1.49	0.32	0.11
Preadipocyte - omental, donor2	11329-117E6	15.28	3.93	0.44	1.31	1.31	0.44	0.87
Preadipocyte - omental, donor3	11403-118D8	15.47	7.02	1.29	2.44	1.72	0.29	0.72
Preadipocyte - perirenal, donor1	11469-119C2	9.84	2.95	0.98	0.98	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	8.91	12.59	1.23	0.61	0.61	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	9.56	7.79	0.71	0.71	1.42	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	11.07	9.03	2.55	1.53	0.68	0.51	0.34
Preadipocyte - visceral, donor1	11280-116I2	12.20	6.24	1.49	1.96	1.58	0.09	0.19
Preadipocyte - visceral, donor2	11357-117H7	14.73	7.82	4.14	2.30	2.30	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	8.78	5.54	1.15	1.99	2.19	0.00	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	9.81	17.20	5.13	0.75	1.21	0.45	1.06
Prostate Epithelial Cells, donor2	11331-117E8	8.80	9.21	3.11	1.08	1.62	0.27	0.00
Prostate Epithelial Cells, donor3	11404-118D9	22.96	17.33	3.06	3.55	3.12	0.31	0.49
Prostate Stromal Cells, donor1	11254-116F3	8.09	7.86	1.48	1.48	1.03	0.11	0.34
Prostate Stromal Cells, donor2	11332-117E9	11.12	13.45	1.26	2.51	1.79	0.00	0.90
Prostate Stromal Cells, donor3	11405-118E1	13.76	13.03	3.23	2.19	2.09	0.31	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	18.61	10.22	0.36	1.46	1.82	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	11.23	11.64	1.32	1.52	1.46	0.07	0.14
Renal Epithelial Cells, donor1	11517-119H5	15.22	5.07	2.03	1.52	2.03	0.00	1.01
Renal Epithelial Cells, donor2	11597-120H4	12.09	7.11	1.42	0.71	2.13	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	14.82	10.06	1.06	1.69	1.80	0.00	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	12.26	9.53	1.36	1.36	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	13.07	7.95	0.27	1.62	1.75	0.00	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	11.10	5.99	0.44	2.22	1.55	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	15.97	13.97	1.33	1.33	3.33	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	19.59	6.60	0.22	0.88	1.54	0.44	0.22
Renal Mesangial Cells, donor2	11598-120H5	15.05	6.27	0.63	1.88	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	16.92	10.26	2.77	2.22	0.83	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	12.08	9.13	1.61	1.07	1.61	0.27	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.96	5.06	1.27	0.84	1.27	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	13.88	6.94	0.77	1.74	2.12	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	11.67	7.78	0.52	1.04	1.30	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	15.63	3.70	0.85	1.99	0.57	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	13.38	4.12	1.03	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	9.53	5.52	0.25	0.75	2.01	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	19.64	19.38	1.20	2.54	2.14	0.40	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	16.08	8.93	0.00	0.00	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	7.71	2.75	1.65	1.10	0.55	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	7.54	2.32	0.58	1.16	1.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	11.44	3.90	0.91	0.65	0.91	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	10.33	8.04	1.09	3.67	1.39	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	10.48	8.92	0.67	1.56	1.45	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	15.38	5.58	0.50	2.36	1.86	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	12.47	8.86	0.82	2.68	1.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	12.71	9.01	0.23	3.47	1.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	13.55	2.74	0.27	3.29	0.96	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	11.80	6.81	0.30	1.51	1.06	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	10.75	6.63	0.72	0.90	0.72	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	17.21	2.73	0.29	2.15	0.72	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	11.48	7.19	0.86	3.11	0.75	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	12.39	6.42	0.66	1.55	1.33	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	12.81	1.91	1.15	1.34	1.34	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	11.09	6.15	0.56	2.42	1.12	0.09	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	14.28	8.83	0.75	1.88	1.13	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	13.14	4.25	1.06	2.39	1.06	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	13.14	7.98	0.39	4.48	0.88	0.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	14.70	5.54	0.38	1.91	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	14.42	5.02	0.32	2.78	1.07	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	12.05	7.85	0.00	3.36	0.84	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	9.06	7.01	0.51	0.85	1.37	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	11.85	5.11	0.36	2.01	1.46	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	12.02	5.89	0.49	2.58	0.74	0.00	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	14.37	8.33	1.21	2.55	1.48	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	16.28	3.77	0.71	0.94	1.89	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	13.89	5.56	0.20	2.58	0.99	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	11.22	5.85	0.70	2.34	0.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	14.10	3.73	2.07	1.24	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	11.28	7.96	0.22	2.65	1.55	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	11.70	4.80	0.42	3.55	1.04	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	17.36	3.23	0.40	1.75	2.42	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	13.11	5.96	1.36	3.58	2.04	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	10.99	7.52	0.96	2.12	1.35	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	13.41	3.27	0.00	1.55	1.72	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	9.05	6.86	0.82	3.43	1.37	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	11.49	6.40	0.49	3.61	1.64	0.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	13.12	2.56	0.34	1.53	2.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	12.13	6.81	1.04	3.40	0.59	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	13.59	5.86	0.27	2.40	0.80	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	18.53	5.25	0.83	3.46	2.35	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	10.00	5.71	0.95	4.76	0.71	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	17.33	7.86	1.21	3.22	1.61	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	18.46	5.74	0.75	3.20	1.13	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	18.17	14.32	1.05	1.75	2.45	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	18.74	9.07	1.51	3.02	3.02	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	16.64	6.24	0.61	1.96	1.22	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	25.33	20.81	2.62	3.35	2.91	0.00	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	20.08	11.56	1.83	3.04	2.43	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	19.59	2.71	0.90	2.41	0.90	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	24.20	20.13	2.71	4.30	3.17	0.23	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	22.77	13.78	5.69	3.89	2.40	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	17.36	8.50	3.31	2.13	2.36	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	17.72	12.38	6.83	2.99	2.35	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	13.82	7.81	2.40	1.80	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	11.85	5.45	0.00	1.88	0.19	0.00	0.19
Schwann Cells, donor2	11578-120F3	10.21	6.80	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	8.11	6.35	0.88	1.31	1.31	0.00	0.00
Sebocyte, donor1	11220-116B5	19.17	19.17	2.19	2.19	1.64	0.00	0.00
Sebocyte, donor2	11301-117B5	14.71	18.38	1.38	0.46	1.38	0.00	0.46
Sebocyte, donor3	11378-118B1	17.31	27.41	1.86	1.03	3.92	0.62	0.62
Sertoli Cells, donor1	11255-116F4	8.28	9.94	3.31	4.97	4.97	0.00	3.31
Sertoli Cells, donor2	11333-117F1	11.30	2.82	0.00	11.30	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	24.37	10.38	2.73	1.85	1.85	0.09	0.09
Skeletal Muscle Cells, donor2	11358-117H8	12.29	13.01	2.89	1.45	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	14.21	3.34	0.00	4.18	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	9.74	4.40	0.94	2.04	0.31	0.00	0.16
Skeletal Muscle Cells, donor5	11455-119A6	8.18	5.20	0.30	2.68	1.93	0.00	0.15
Skeletal Muscle Cells, donor6	11459-119B1	8.77	2.00	0.92	1.08	1.39	0.00	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	13.61	5.67	0.88	1.01	0.76	0.13	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	14.13	6.56	0.71	1.43	0.86	0.14	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	10.42	6.65	0.40	1.39	1.09	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	18.79	11.80	1.10	2.11	2.70	0.00	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	13.75	7.24	0.00	2.90	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	10.87	7.71	0.69	1.38	2.06	0.28	0.00
Skin - palm, donor1	10286-104F7	8.06	29.55	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	6.34	6.92	0.86	1.01	1.44	0.29	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.00	3.27	0.00	0.00	3.27	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.88	8.05	0.78	0.78	1.69	0.13	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	7.23	8.34	0.83	0.70	1.25	0.70	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	16.74	10.83	1.69	2.11	1.83	0.42	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	11.21	9.94	0.21	1.90	1.90	0.00	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	20.46	18.59	3.00	3.30	3.00	0.37	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	9.57	4.01	0.62	0.62	1.23	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	14.67	5.34	0.44	2.89	2.45	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	8.82	7.05	0.59	1.18	1.18	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	10.83	11.27	0.66	0.88	1.33	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	3.94	6.69	0.79	0.79	0.79	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	6.18	10.04	0.77	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	17.01	12.01	1.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	7.19	4.79	0.80	0.67	0.93	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	14.19	6.21	1.11	1.99	1.55	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	5.25	4.61	1.54	0.90	0.77	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	9.77	5.86	0.65	0.98	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	7.97	7.09	0.59	0.59	1.18	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	8.83	5.13	0.43	1.57	1.28	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	10.74	7.97	0.65	0.98	1.95	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	17.66	4.57	0.61	2.13	1.52	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	13.13	9.60	2.78	1.26	1.52	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	13.83	5.25	0.48	1.43	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	8.11	6.05	0.15	0.74	0.44	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	8.61	5.38	0.43	0.86	2.15	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	10.71	5.98	0.52	1.36	1.15	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	9.44	7.89	0.77	1.39	1.39	0.15	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	8.62	7.55	0.00	1.08	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	10.16	5.08	0.30	1.20	0.90	0.00	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	12.29	9.56	1.02	2.05	2.05	0.00	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	15.23	10.60	0.63	1.10	1.73	0.00	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	13.08	7.75	6.04	2.21	1.31	0.40	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	14.11	14.11	0.68	0.91	3.19	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.85	6.04	0.00	2.42	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	11.13	8.74	0.79	0.79	1.32	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	15.71	10.12	1.60	1.07	1.73	0.13	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	12.77	9.14	2.00	1.75	1.88	0.25	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	9.39	10.15	2.54	1.01	1.27	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	10.86	10.55	1.36	1.06	1.81	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	17.25	11.25	2.25	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	16.80	31.01	3.88	0.00	19.38	1.29	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	15.81	8.84	0.00	0.47	1.86	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	13.13	12.62	0.50	1.51	1.51	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	14.10	9.40	0.94	1.88	1.88	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	9.44	5.60	0.00	0.59	1.18	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	11.00	6.75	0.92	0.92	2.17	0.00	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	21.02	5.61	0.47	2.80	3.27	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	8.20	6.04	1.01	0.58	0.72	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	8.41	4.59	0.76	0.76	2.04	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.46	3.38	0.56	1.32	1.13	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	10.34	6.01	0.98	1.82	0.70	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	11.65	7.04	0.34	1.51	0.92	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	9.05	3.81	0.00	1.90	0.95	0.95	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	9.30	4.89	0.49	0.00	1.22	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	9.72	6.41	1.55	1.55	1.77	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	10.24	6.44	0.00	1.17	1.17	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	17.88	8.94	1.17	1.55	2.33	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	7.93	7.40	0.79	1.06	2.12	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	6.70	4.46	0.37	0.37	0.37	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	7.55	6.47	1.80	1.08	0.36	0.36	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	4.83	6.25	0.57	0.85	1.42	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	5.91	5.91	0.39	1.18	1.58	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	9.65	4.06	2.03	1.27	1.52	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	17.17	5.19	1.20	1.20	3.19	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	10.87	9.61	1.67	2.09	4.18	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	9.63	5.50	1.38	0.92	1.83	0.00	0.92
Synoviocyte, donor1	11291-117A4	10.10	10.44	1.68	1.18	1.68	0.00	0.17
Synoviocyte, donor2	11368-117I9	11.90	10.39	1.51	2.35	1.84	0.17	0.50
Synoviocyte, donor3	11440-118H9	14.30	8.94	0.89	1.34	1.79	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	14.29	6.07	0.00	1.79	2.14	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	3.96	0.00	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	14.82	9.49	0.46	3.24	1.39	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	9.10	8.53	0.93	0.57	1.72	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	8.50	8.12	0.39	0.77	0.77	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	10.88	4.58	0.57	1.15	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	16.73	18.08	1.85	1.35	2.21	0.37	0.74
Urethra, donor2	10319-105A4	12.59	7.19	5.40	1.80	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	12.49	8.50	0.53	2.13	0.80	0.00	0.00
Urothelial Cells, donor2	11600-120H7	7.61	10.41	0.80	1.20	1.20	0.00	0.40
Urothelial Cells, donor3	11681-122H7	18.57	17.42	1.15	1.60	2.52	0.00	0.23
Urothelial cells, donor0	11216-116B1	14.04	14.04	0.00	1.11	0.45	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	27.58	28.47	1.78	1.78	6.23	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	27.16	51.47	0.00	0.00	4.29	0.00	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	29.43	21.90	1.37	2.74	6.16	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	22.73	24.79	0.69	0.69	2.41	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	27.89	26.15	1.16	0.58	4.65	0.00	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	28.11	24.99	0.00	1.04	8.33	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	32.12	25.70	0.00	0.00	8.26	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	33.78	29.21	0.00	2.74	5.48	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	11.72	8.76	1.60	1.85	1.85	0.12	0.25
Wilms' tumor cell line:HFWT	10597-108E3	5.28	7.92	0.88	0.00	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	15.36	19.27	3.07	2.79	2.23	0.00	0.28
achilles tendon, donor2	10292-104G4	2.07	2.07	2.07	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	6.12	5.61	0.25	1.53	0.76	0.00	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	9.52	8.82	0.93	0.70	1.86	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	26.23	19.23	2.14	3.21	3.80	0.12	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	13.06	12.52	1.36	1.90	2.18	0.54	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	13.49	7.87	0.56	1.41	2.25	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	10.57	14.38	2.11	1.06	1.27	0.00	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	15.52	13.61	1.63	1.09	2.45	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	6.17	13.22	0.00	0.88	0.88	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	8.98	8.17	2.04	0.00	1.63	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	12.81	7.38	0.78	0.39	1.94	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	11.41	4.42	1.10	2.02	3.13	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	15.60	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	9.76	8.13	1.86	2.32	2.32	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	9.32	4.92	1.29	1.04	0.52	0.26	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	8.48	5.84	1.75	1.75	1.75	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	4.65	7.44	2.32	0.00	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	7.40	8.23	1.23	0.41	0.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	8.29	4.30	0.92	0.61	0.61	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	8.11	7.68	1.71	0.85	0.85	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	9.10	9.40	2.12	2.43	1.21	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	6.74	9.87	0.72	0.48	1.20	0.00	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	13.81	8.46	0.89	1.56	0.89	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	12.01	5.67	1.33	0.33	2.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	11.15	13.01	0.00	0.00	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	13.94	9.04	0.00	1.88	3.01	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	14.83	9.16	2.18	2.18	1.74	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	5.62	9.37	3.75	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	14.37	14.84	0.71	1.18	2.35	0.00	0.47
adipose tissue, adult, pool1	10010-101C1	14.74	12.10	2.02	0.93	2.48	0.16	0.16
adipose, donor1	10184-103D4	2.93	5.28	5.86	0.59	1.17	0.59	0.00
adipose, donor2	10185-103D5	20.28	18.65	11.76	2.43	0.81	0.00	0.81
adipose, donor3	10186-103D6	17.43	16.07	9.80	1.91	1.63	0.54	2.18
adipose, donor4	10187-103D7	15.60	9.53	9.53	4.33	4.33	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	19.57	6.47	1.26	3.00	1.42	0.16	0.16
adrenal gland, adult, pool1	10081-102A9	21.83	21.83	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	7.20	3.87	0.27	1.07	0.40	0.13	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	8.93	9.29	0.71	2.14	2.14	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	21.10	7.88	1.16	2.32	0.70	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	17.24	8.45	1.01	3.72	2.37	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	18.56	5.60	0.59	2.65	2.65	0.29	0.29
amygdala - adult, donor10196	10167-103B5	33.20	11.86	5.93	2.37	1.19	0.00	1.19
amygdala, adult, donor10252	10151-102I7	28.59	26.36	7.91	3.65	3.65	0.20	1.01
amygdala, newborn, donor10223	10360-105E9	14.85	9.04	2.90	2.26	0.65	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	11.84	7.00	1.27	1.15	1.53	0.13	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	10.81	5.96	1.32	2.21	1.32	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	25.72	8.02	0.33	4.34	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	20.01	16.67	1.18	2.75	0.98	0.00	0.59
appendix, adult	10189-103D9	20.18	19.41	4.27	2.72	1.16	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	14.45	6.19	3.44	0.69	0.00	0.00	0.34
artery, adult	10190-103E1	8.15	20.38	1.36	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	14.78	6.81	1.45	2.03	0.72	0.00	0.14
b cell line:RPMI1788	10427-106D4	12.34	10.71	0.74	1.34	1.04	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	6.38	6.10	0.28	0.55	0.00	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	12.11	10.42	0.89	2.38	1.39	0.00	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	10.71	3.85	0.84	1.67	1.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	6.15	4.47	2.80	0.56	0.00	0.56	0.00
bladder, adult, pool1	10011-101C2	15.86	14.34	2.17	0.65	1.41	0.43	0.43
blood, adult, pool1	10053-101G8	22.15	24.36	0.00	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.13	4.28	0.86	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	12.82	21.59	0.00	1.35	1.35	0.67	0.00
brain, adult, donor1	10084-102B3	49.20	27.68	17.43	5.13	3.08	0.00	0.00
brain, adult, pool1	10012-101C3	23.72	14.92	9.58	4.45	1.78	0.33	1.34
brain, fetal, pool1	10085-102B4	64.11	16.03	8.01	13.36	2.67	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	14.21	15.53	1.98	2.31	1.98	0.33	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	15.60	7.24	0.62	2.37	1.62	0.00	0.25
breast, adult, donor1	10080-102A8	20.20	14.52	1.26	3.16	2.53	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	14.10	3.94	2.41	2.16	2.54	0.25	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	12.37	7.42	1.86	2.78	1.55	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	9.67	2.53	0.23	1.61	1.15	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	14.77	7.26	0.97	2.18	2.66	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	5.17	1.88	0.47	0.94	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	19.47	18.05	3.94	3.39	1.75	0.00	1.20
carcinoid cell line:SK-PN-DW	10719-109I8	13.31	4.12	0.95	1.90	0.95	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	33.27	11.98	3.19	5.32	2.13	0.27	0.00
caudate nucleus - adult, donor10196	10177-103C6	26.48	12.66	5.76	2.30	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	41.66	16.06	6.86	4.18	2.84	0.17	0.50
caudate nucleus, adult, donor10258	10379-105H1	33.62	9.17	6.88	8.41	3.06	1.53	1.53
caudate nucleus, newborn, donor10223	10354-105E3	29.66	9.16	3.66	4.76	2.20	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	26.22	26.22	2.91	0.00	8.74	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	45.69	40.57	11.96	4.70	4.06	0.21	2.56
cerebellum, adult, pool1	10083-102B2	25.53	19.32	6.90	6.21	2.41	0.00	0.69
cerebellum, newborn, donor10223	10357-105E6	22.42	11.62	5.81	1.66	5.81	2.49	0.00
cerebral meninges, adult	10188-103D8	17.65	8.32	6.56	4.03	2.02	0.25	0.76
cerebrospinal fluid, donor2	10294-104G6	7.31	8.04	1.46	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	14.09	7.19	1.15	1.01	1.58	0.00	0.29
cervical cancer cell line:ME-180	10553-107I4	10.27	14.25	0.66	0.66	1.16	0.00	0.33
cervix, adult, pool1	10013-101C4	30.34	23.52	5.88	3.15	2.94	0.31	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	11.70	8.64	1.53	0.70	0.70	0.28	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	7.84	2.61	1.31	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	16.40	12.18	5.10	3.85	2.61	0.62	0.50
choriocarcinoma cell line:SCH	10785-110H2	14.29	4.68	0.99	2.09	0.74	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	18.74	3.79	1.42	3.56	1.19	0.47	0.24
chorionic membrane cells, donor1	12238-129G6	18.52	7.41	0.28	2.56	1.14	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	16.51	8.35	1.79	1.29	1.99	0.30	0.10
chorionic membrane cells, donor3	12240-129G8	20.88	5.49	0.00	4.95	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	3.03	11.11	6.06	0.00	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	8.45	7.88	0.96	1.15	0.58	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	7.18	5.91	2.53	0.21	0.63	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	11.30	6.16	0.77	1.54	1.03	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	9.68	4.60	0.97	0.24	2.18	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	8.96	8.14	0.41	0.81	2.24	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	7.95	7.95	0.59	1.18	0.88	0.00	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	9.38	12.25	0.52	0.52	1.30	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	10.74	9.60	1.60	2.51	0.69	0.23	0.46
clear cell carcinoma cell line:TEN	10636-108I6	11.45	10.24	1.21	1.39	0.69	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	13.36	11.53	2.93	1.46	1.65	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	29.65	22.04	0.38	4.56	1.90	0.00	0.38
colon, adult, donor1	10082-102B1	22.61	21.42	4.76	7.14	2.38	0.00	1.19
colon, adult, pool1	10014-101C5	22.21	24.68	6.58	2.00	2.59	0.35	0.82
colon, fetal, donor1	10070-101I7	39.55	28.43	3.09	3.71	5.56	0.62	1.24
common myeloid progenitor CMP, donor1	12130-128D6	41.25	32.08	9.17	0.00	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	11.90	22.10	1.70	0.42	2.97	1.27	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	14.49	32.45	9.21	0.75	4.68	0.00	1.96
cord blood derived cell line:COBL-a untreated	10449-106F8	15.37	29.33	2.26	1.55	3.53	0.14	1.27
corpus callosum, adult, pool1	10042-101F6	32.39	46.99	13.05	2.76	2.43	0.77	3.10
cruciate ligament, donor2	10295-104G7	7.29	8.10	1.62	0.81	0.00	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	9.63	13.64	0.00	0.80	0.80	0.00	0.80
diencephalon, adult	10193-103E4	17.28	11.04	4.56	2.40	1.68	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	8.73	9.87	2.07	0.46	0.92	0.00	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	24.87	25.13	4.10	2.82	3.85	0.26	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	9.15	12.04	0.96	1.44	2.41	0.00	0.24
ductus deferens, adult	10196-103E7	33.89	13.95	1.50	2.99	2.49	0.00	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	30.24	20.16	0.00	0.00	4.32	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	30.90	19.86	1.47	2.21	4.41	0.74	1.47
dura mater, adult, donor1	10041-101F5	22.96	14.78	1.57	2.40	2.31	0.25	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	7.33	20.43	10.66	0.44	2.00	0.44	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	11.03	21.49	3.87	1.58	2.58	0.00	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	17.27	6.78	0.62	0.00	3.08	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	15.74	8.78	0.91	1.82	1.51	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	9.57	9.57	0.62	1.54	2.16	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	15.76	7.88	1.31	1.31	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	30.17	19.11	4.02	4.36	4.02	0.00	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	19.39	6.71	1.09	3.62	0.72	0.00	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	9.17	9.01	0.64	1.61	1.93	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	13.01	15.01	1.78	2.11	1.33	0.11	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	11.88	12.98	0.44	1.98	1.54	0.11	0.22
epididymis, adult	10197-103E8	18.63	14.86	2.72	3.56	1.05	0.21	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	23.60	7.81	0.89	3.37	3.02	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	11.80	7.47	0.00	2.75	1.57	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	13.37	6.29	1.05	1.83	0.79	0.00	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	16.73	9.25	1.48	2.17	1.38	0.00	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	13.11	7.84	1.23	1.34	1.23	0.00	0.00
esophagus, adult, pool1	10015-101C6	20.70	26.65	2.76	1.59	3.93	0.32	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	32.56	32.19	4.88	4.63	5.39	0.13	0.38
eye - muscle inferior rectus, donor1	10272-104E2	9.66	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	0.00	4.21	0.00	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	10.42	4.46	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	14.90	5.73	0.00	1.15	3.44	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	13.12	4.37	1.46	0.00	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	20.59	13.22	2.29	2.54	2.54	0.51	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	11.92	4.36	0.90	1.03	1.54	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	14.48	8.78	1.42	2.85	2.61	0.00	0.71
frontal lobe, adult, pool1	10040-101F4	34.90	17.17	12.48	3.85	2.35	0.84	1.60
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	31.83	13.51	1.80	4.20	3.90	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	7.31	5.85	0.73	0.91	0.73	0.09	0.27
gall bladder, adult	10198-103E9	17.38	21.49	6.28	3.38	2.17	0.24	1.21
gamma delta positive T cells, donor1	11937-126A2	19.33	14.50	1.07	0.54	2.15	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	17.55	16.81	0.75	1.87	0.37	0.37	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	19.64	9.50	0.63	1.69	0.63	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	20.12	9.67	1.55	2.32	2.51	0.39	0.58
gastric cancer cell line:AZ521	10549-107H9	20.00	8.85	2.62	4.26	0.66	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	30.20	7.32	1.83	4.58	5.49	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	25.82	30.16	4.34	1.83	3.88	0.91	1.14
giant cell carcinoma cell line:LU65	10487-107B1	4.47	4.70	0.11	0.46	0.46	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	38.49	27.29	1.40	5.74	3.78	0.14	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	13.47	13.22	1.50	2.24	2.00	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	10.03	5.49	0.32	2.01	0.84	0.00	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	10.67	5.76	0.28	2.11	0.42	0.14	0.28
glioblastoma cell line:T98G	10485-107A8	8.50	6.95	0.66	0.55	0.33	0.00	0.22
glioma cell line:GI-1	10413-106B8	18.74	10.84	2.93	2.34	2.34	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	19.68	10.93	5.83	0.00	0.00	0.73	1.46
globus pallidus, adult, donor10252	10161-103A8	29.05	35.39	6.83	2.44	1.22	0.49	1.71
globus pallidus, adult, donor10258	10367-105F7	12.32	19.17	4.11	0.00	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	15.45	18.12	2.66	5.33	2.66	1.07	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	48.94	48.94	22.02	4.89	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	0.00	0.00	5.23	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	8.32	4.80	1.28	1.28	1.28	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	16.07	5.05	0.46	0.92	1.84	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	13.72	3.66	0.46	0.00	1.83	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	9.66	0.00	0.00	0.00	1.93	0.64	0.00
hIPS, biol_rep1	14380-156B6	5.75	0.00	0.00	0.00	2.87	1.44	0.00
hIPS, biol_rep2	14381-156B7	7.54	1.37	2.06	0.00	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	26.48	5.52	8.83	1.10	2.21	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	10.06	19.83	2.01	2.59	2.59	0.00	0.29
heart - mitral valve, adult	10205-103F7	11.36	14.65	3.59	2.09	0.30	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	17.52	13.60	2.09	2.88	2.88	0.26	0.78
heart - tricuspid valve, adult	10207-103F9	9.99	15.82	0.83	0.00	1.67	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	21.02	12.24	2.24	2.04	1.43	0.00	0.61
heart, adult, diseased, donor1	10051-101G6	10.22	13.20	2.13	2.55	2.98	0.00	0.00
heart, adult, pool1	10016-101C7	9.89	9.43	1.84	0.69	1.61	0.00	0.46
heart, fetal, pool1	10046-101G1	29.16	25.16	4.00	2.67	2.46	0.10	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	10.49	4.01	0.62	0.62	0.93	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	10.70	8.32	4.76	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	13.15	15.03	2.10	1.44	2.21	0.00	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	12.99	15.05	1.46	1.21	1.70	0.00	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	16.67	13.04	1.72	3.13	1.62	0.20	0.40
hepatoma cell line:Li-7	10484-107A7	12.68	9.12	0.44	0.33	1.33	0.22	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	9.85	10.05	1.71	1.61	1.21	0.10	0.20
hippocampus - adult, donor10196	10169-103B7	19.87	9.46	8.52	3.79	1.89	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	28.98	27.35	6.53	4.08	2.45	0.20	1.02
hippocampus, adult, donor10258	10374-105G5	14.44	1.99	2.99	0.00	1.99	1.99	0.50
hippocampus, newborn, donor10223	10363-105F3	26.44	9.52	4.58	6.34	3.88	0.35	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	8.54	12.21	2.44	0.61	0.00	1.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	18.26	14.53	2.16	4.52	2.95	0.39	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	13.71	14.98	2.54	2.79	1.52	0.76	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	23.12	18.04	8.46	6.20	1.13	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	22.46	27.63	11.36	4.39	2.58	2.58	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	11.01	20.12	7.97	2.28	2.28	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	12.26	9.93	9.05	3.21	1.17	1.17	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	24.13	17.02	10.99	4.95	2.59	1.29	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	17.93	18.35	12.10	6.26	1.25	2.09	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	14.92	10.89	8.76	3.32	1.42	0.71	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	25.71	17.36	10.29	3.54	2.41	1.13	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	21.55	16.16	12.12	3.37	2.69	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	18.47	17.84	6.42	2.97	1.72	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	11.79	9.33	8.84	1.47	1.47	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	3.49	5.24	1.75	0.87	0.87	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	24.25	37.99	19.47	6.68	2.48	0.38	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	25.29	23.11	20.06	4.36	2.18	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	10.00	13.99	14.99	2.00	1.00	1.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	16.39	17.71	10.93	1.88	0.75	0.75	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	21.37	16.82	10.91	2.73	0.91	0.45	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	11.28	11.28	10.65	1.25	0.94	0.94	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	17.47	14.37	11.76	1.96	2.12	0.82	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	10.16	11.61	9.58	2.32	1.16	0.58	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	15.25	13.45	12.26	2.69	2.09	0.90	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	16.44	18.47	4.25	4.06	2.40	0.92	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	17.12	14.83	6.28	2.85	3.14	0.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	9.80	12.25	3.27	2.04	0.82	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	18.31	16.20	11.97	2.46	1.41	1.41	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	19.64	21.54	10.14	3.17	1.90	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	14.83	15.43	10.29	2.42	1.21	0.91	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.93	10.86	13.45	2.59	1.55	0.52	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	17.27	12.62	12.62	5.98	1.33	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	10.26	12.06	9.24	1.03	1.80	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	14.32	13.29	8.95	1.53	2.56	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	24.23	13.63	15.14	3.79	5.30	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	13.78	9.07	6.05	3.02	1.01	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	16.42	15.94	6.52	2.17	2.17	0.48	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	7.58	8.02	7.58	1.78	1.34	0.89	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	13.17	7.80	2.93	4.88	3.41	0.00	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	17.11	20.17	13.45	3.97	3.06	0.31	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	3.25	0.00	6.51	0.00	6.51	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	7.94	7.28	10.59	0.00	2.32	0.99	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	13.68	13.68	16.42	3.83	2.19	2.74	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	11.94	7.96	10.49	1.81	1.09	1.09	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	8.19	12.46	6.41	1.78	2.14	0.71	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	10.74	9.55	7.16	0.00	1.19	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	11.10	11.38	10.56	1.63	1.22	0.54	0.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	11.31	9.70	6.20	1.62	0.00	0.27	0.54
immature langerhans cells, donor1	11904-125F5	6.54	7.26	0.48	0.48	0.73	0.00	0.00
immature langerhans cells, donor2	11905-125F6	17.43	22.97	0.79	1.58	4.75	0.00	0.00
insula, adult, pool1	10039-101F3	40.12	18.55	14.38	4.54	3.03	1.14	2.18
keratoacanthoma cell line:HKA-1	10791-110H8	13.33	8.13	0.33	1.30	1.30	0.00	0.98
kidney, adult, pool1	10017-101C8	16.02	16.52	2.80	1.50	1.20	0.10	0.40
kidney, fetal, pool1	10045-101F9	32.61	22.14	3.61	2.69	2.41	0.35	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	38.35	26.56	6.11	3.12	5.40	0.85	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	7.74	5.67	0.97	1.11	0.97	0.00	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	10.28	11.74	1.28	0.92	0.55	0.00	0.18
left atrium, adult, donor1	10079-102A7	15.26	9.81	1.09	3.27	2.72	0.00	1.09
left ventricle, adult, donor1	10078-102A6	15.17	12.64	0.51	1.01	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	10.12	4.92	0.55	2.46	1.37	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	10.78	13.65	1.08	1.08	2.16	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	8.15	7.07	0.54	0.54	0.00	0.00	0.54
leiomyoma cell line:15425	10571-108B4	8.01	8.01	0.97	0.73	0.97	0.49	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	20.91	11.50	0.00	3.14	3.14	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	9.33	5.31	0.35	1.18	1.30	0.12	0.12
liposarcoma cell line:KMLS-1	10782-110G8	7.97	5.78	0.78	1.41	1.87	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	13.16	8.04	0.97	2.19	0.73	0.00	0.00
liver, adult, pool1	10018-101C9	10.37	7.94	1.62	0.32	2.43	0.00	0.16
liver, fetal, pool1	10086-102B5	12.23	20.70	0.94	3.76	1.88	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	17.35	28.44	6.42	3.21	0.87	0.00	1.02
locus coeruleus, adult, donor10252	10165-103B3	21.59	30.27	3.69	1.85	2.40	0.37	1.11
locus coeruleus, adult, donor10258	10375-105G6	17.21	14.95	7.62	2.26	3.10	0.00	0.56
locus coeruleus, newborn, donor10223	10362-105F2	11.36	7.15	3.79	0.42	0.42	0.00	0.84
lung adenocarcinoma cell line:A549	10499-107C4	11.49	5.12	0.42	1.94	1.38	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	7.58	6.89	1.38	0.00	1.38	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	13.05	8.57	1.05	3.69	1.45	0.13	0.53
lung, adult, pool1	10019-101D1	16.07	15.47	1.77	1.54	2.13	0.24	0.35
lung, fetal, donor1	10068-101I5	32.82	16.55	3.42	2.00	4.00	0.29	0.00
lung, right lower lobe, adult, donor1	10075-102A3	30.70	26.12	4.58	5.04	4.12	0.00	0.92
lymph node, adult, donor1	10077-102A5	23.67	16.09	2.37	2.37	2.37	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	12.49	8.99	1.10	2.41	0.44	0.44	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	10.41	6.19	0.91	0.75	0.75	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	20.39	16.99	4.25	4.25	5.10	0.85	0.00
mature adipocyte, donor1	12231-129F8	17.76	15.98	3.11	0.00	1.33	0.44	0.44
mature adipocyte, donor2	12232-129F9	12.24	13.07	2.28	0.83	1.45	0.00	0.42
mature adipocyte, donor3	12233-129G1	10.43	9.48	2.61	0.71	1.19	0.24	0.24
mature adipocyte, donor4	12234-129G2	12.90	12.11	1.32	1.05	1.32	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	33.83	17.39	6.19	4.53	3.81	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	31.58	4.51	7.90	1.13	2.26	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	31.26	24.28	6.25	4.41	4.23	0.18	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	20.01	6.04	6.67	1.91	1.27	0.95	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	15.78	2.99	5.97	2.13	1.71	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	28.18	16.54	10.46	4.39	2.87	0.84	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	24.41	22.28	7.85	3.61	3.18	0.64	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	3.85	0.00	1.93	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	22.25	6.46	7.18	4.67	2.87	1.08	0.72
medulla oblongata - adult, donor10196	10174-103C3	9.09	6.49	4.54	0.65	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	24.15	28.17	3.25	2.48	3.10	0.31	0.77
medulla oblongata, adult, pool1	10038-101F2	24.08	24.24	8.00	2.53	2.94	0.73	1.39
medulla oblongata, newborn, donor10223	10361-105F1	16.66	18.75	4.17	2.08	2.08	0.35	0.69
medulloblastoma cell line:D283 Med	10838-111E1	30.33	8.19	1.11	3.99	3.76	0.22	0.22
medulloblastoma cell line:ONS-76	10759-110E3	7.70	3.67	1.22	1.71	1.35	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	13.66	7.19	3.16	1.15	2.01	0.29	0.00
melanoma cell line:G-361	10465-106H6	13.84	5.97	5.43	2.44	2.71	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	7.96	6.15	0.18	1.09	0.90	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	32.60	16.74	2.64	5.29	3.52	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	31.88	12.70	2.33	6.74	1.81	0.00	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	8.75	4.60	0.31	1.07	0.92	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	13.63	5.82	0.18	1.27	1.64	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	7.45	5.38	0.00	0.83	0.83	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	9.55	6.74	1.26	1.26	1.69	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	12.13	8.28	0.96	2.12	0.58	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	15.96	7.63	0.69	1.39	2.08	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	11.33	7.04	1.03	1.54	1.37	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	9.43	6.90	0.69	2.07	1.50	0.23	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	9.82	6.37	0.53	1.33	1.59	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	10.13	5.54	0.27	1.76	2.03	0.00	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	8.82	7.40	0.43	2.13	1.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	10.87	5.60	0.33	1.32	1.98	0.99	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	10.79	5.26	0.28	1.80	1.38	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	8.03	6.28	0.35	0.35	1.05	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	8.17	3.88	0.61	0.61	0.20	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.02	4.67	1.80	1.08	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	9.52	4.03	0.52	2.17	0.52	0.10	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	6.16	4.33	0.46	0.91	0.68	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	3.36	3.36	0.84	2.52	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	11.06	4.78	1.05	0.30	0.75	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	10.07	4.64	0.18	2.19	1.49	0.09	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	12.89	5.89	0.74	0.37	1.47	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	8.01	5.44	0.57	1.43	1.14	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	4.63	3.37	0.00	0.42	1.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	5.48	3.65	0.46	0.91	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.98	4.86	1.28	1.28	2.05	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	7.33	5.24	1.31	0.52	1.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	12.32	5.55	0.62	0.62	2.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	8.94	5.88	1.18	1.41	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	10.83	7.11	0.68	1.35	1.35	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	10.61	5.11	1.18	1.57	2.75	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	8.34	3.24	1.85	0.93	2.78	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	12.40	5.77	0.29	2.02	1.44	0.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	9.15	8.70	0.67	0.45	2.90	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	10.09	5.77	0.72	0.96	1.92	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	13.93	10.27	0.00	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	12.08	4.03	1.01	1.34	1.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	8.60	5.32	1.23	0.82	1.64	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	9.88	7.30	0.00	0.43	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	10.94	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	0.00	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	5.20	2.92	0.32	1.95	1.95	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	4.36	2.91	1.45	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	9.06	7.46	1.07	0.53	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	5.72	4.91	0.82	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	7.77	3.11	0.78	0.00	0.78	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	4.20	4.20	2.10	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	6.95	4.97	0.99	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	19.07	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.12	4.74	0.00	1.19	1.19	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	6.09	7.31	1.22	1.22	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	12.67	2.53	0.00	0.00	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	7.24	4.48	0.69	1.38	1.03	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	6.45	0.00	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	7.98	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	3.44	6.89	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	7.33	6.11	0.00	0.00	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.94	1.59	0.79	0.00	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.07	4.72	0.59	0.59	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	7.48	4.99	0.31	0.62	1.25	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	10.69	10.69	0.00	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	8.28	5.91	2.37	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	5.51	3.44	1.38	0.00	2.75	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	8.91	3.46	0.99	0.49	2.47	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	11.22	0.00	0.00	3.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.90	6.36	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	10.48	6.45	0.81	0.40	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	2.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	15.20	3.80	1.27	0.00	0.00	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	11.53	11.53	2.43	0.61	1.21	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	9.04	0.00	4.52	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	14.00	9.88	0.82	0.82	2.47	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	6.75	5.16	1.19	0.40	0.60	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	9.41	5.84	1.30	0.97	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	11.20	7.13	0.00	1.02	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	8.51	7.74	0.00	0.77	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	13.94	7.80	0.00	2.60	0.47	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	17.84	11.82	1.39	2.32	1.85	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	0.00	8.55	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	8.12	7.09	0.82	0.51	1.03	0.10	0.00
mesothelioma cell line:Mero-25	10850-111F4	14.98	11.12	0.68	2.04	1.82	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	16.14	6.36	0.73	2.93	2.44	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	7.53	8.64	1.33	1.33	0.66	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	18.40	12.88	1.05	2.89	2.89	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	13.62	9.19	0.85	1.53	2.89	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	18.20	14.41	1.26	1.52	3.54	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	24.43	11.18	2.90	4.14	2.48	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	12.75	12.75	1.33	1.99	1.33	0.17	0.33
mesothelioma cell line:NCI-H226	10846-111E9	8.51	12.49	0.54	0.90	1.63	0.00	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	15.20	11.62	0.51	2.22	2.22	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	13.49	3.56	0.51	2.29	1.53	0.00	0.00
mesothelioma cell line:No36	10857-111G2	10.76	8.16	0.33	2.28	2.94	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	13.55	7.86	0.81	1.35	4.06	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	6.14	7.48	0.58	0.19	0.58	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	4.27	7.94	0.49	0.49	0.61	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	6.28	6.64	0.54	0.18	0.90	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	11.75	7.84	0.98	1.31	0.33	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	9.11	2.54	0.64	0.85	0.64	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	9.68	5.99	0.69	0.46	1.61	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	7.80	4.38	0.95	0.57	1.33	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	8.13	3.70	0.74	0.92	0.55	0.37	0.18
myeloma cell line:PCM6	10474-106I6	6.13	3.95	0.40	0.20	0.59	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	4.57	3.55	1.52	2.03	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	18.04	8.43	0.59	3.33	2.75	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	14.71	12.15	1.11	2.12	2.79	0.11	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	11.69	10.30	0.81	1.25	1.47	0.07	0.37
nasal epithelial cells, donor2	12227-129F4	14.35	6.62	2.21	0.55	2.21	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	35.89	13.57	2.99	4.37	1.84	0.46	0.46
neuroblastoma cell line:NB-1	10539-107G8	25.63	13.66	2.06	2.99	3.18	0.37	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	19.40	10.12	1.69	1.48	2.11	0.21	0.42
neuroblastoma cell line:NH-12	10555-107I6	37.83	14.35	1.86	3.54	2.42	0.37	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	17.32	9.25	1.42	0.71	1.90	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	27.40	11.09	4.43	3.80	1.74	0.32	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	12.28	4.43	0.60	1.41	1.21	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	22.89	7.63	2.54	1.91	1.91	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	10.11	6.65	0.00	1.06	0.80	0.00	0.53
neutrophil PMN, donor1	12133-128D9	59.50	44.62	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	13.28	0.00	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	20.46	19.96	1.52	3.38	1.69	0.00	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	28.02	25.62	7.20	12.81	2.40	0.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	13.47	11.22	0.96	1.92	1.92	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	9.46	4.99	0.53	1.05	0.53	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	35.81	21.00	12.37	3.75	2.25	0.37	1.87
occipital cortex - adult, donor10196	10172-103C1	22.66	14.42	6.18	4.12	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	25.49	32.74	12.08	1.88	2.68	0.54	1.07
occipital cortex, newborn, donor10223	10355-105E4	33.12	8.01	6.55	9.83	3.28	0.36	1.46
occipital lobe, adult, donor1	10076-102A4	43.82	23.35	14.96	6.04	3.67	0.00	2.36
occipital lobe, fetal, donor1	10073-102A1	65.65	24.46	7.72	15.88	4.29	2.15	1.72
occipital pole, adult, pool1	10036-101E9	32.96	17.74	8.59	3.86	1.89	0.71	1.26
olfactory region, adult	10195-103E6	23.88	17.96	12.99	2.48	2.29	0.57	0.19
optic nerve, donor1	10277-104E7	46.02	40.02	24.01	6.00	2.00	4.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	26.88	43.63	4.44	4.21	4.10	0.46	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	10.30	14.29	1.51	1.24	2.06	0.00	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	18.96	10.84	0.85	1.02	1.35	0.00	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	24.60	12.01	1.39	2.19	3.58	0.23	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	13.82	7.35	0.88	1.76	2.35	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	3.74	4.67	2.80	2.80	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	10.82	9.33	2.12	2.12	2.33	0.00	0.42
ovary, adult, pool1	10020-101D2	22.45	23.85	3.41	1.83	2.18	0.26	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	6.42	4.95	0.55	0.37	0.37	0.00	0.18
pancreas, adult, donor1	10049-101G4	27.28	13.17	2.82	4.70	2.82	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	37.18	20.97	3.91	5.03	3.91	0.28	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	7.15	6.30	0.17	1.19	1.70	0.17	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	14.07	13.25	1.82	0.99	1.82	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	33.68	19.31	11.71	3.48	2.65	1.19	2.11
parietal cortex, adult, donor10258	10373-105G4	19.08	3.67	5.87	0.73	1.47	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	20.69	13.17	7.52	0.00	0.94	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	28.22	22.23	8.55	3.42	2.00	0.29	0.57
parietal lobe, adult, pool1	10034-101E7	33.75	20.97	10.49	3.52	1.85	0.79	2.38
parietal lobe, fetal, donor1	10072-101I9	63.04	28.13	4.85	9.70	6.79	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	17.95	9.35	3.36	3.74	1.12	0.37	0.00
parotid gland, adult	10199-103F1	17.27	9.87	1.85	2.47	3.08	0.00	0.00
penis, adult	10200-103F2	20.41	13.96	5.37	4.83	1.07	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	22.68	5.95	0.74	2.60	1.49	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	22.15	12.24	1.60	1.46	1.31	0.44	0.15
pineal gland - adult, donor10196	10179-103C8	15.48	7.10	7.74	1.29	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	24.28	15.99	11.25	2.96	0.59	0.00	1.78
pineal gland, adult, donor10258	10377-105G8	16.30	10.03	5.02	2.51	0.00	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	26.31	8.09	2.02	2.02	0.00	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	43.26	28.66	3.65	5.21	2.08	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	27.24	6.81	2.55	4.26	4.26	0.00	0.00
placenta, adult, pool1	10021-101D3	28.70	18.38	2.47	4.19	3.55	0.00	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	9.01	8.34	0.26	1.19	1.99	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	12.30	7.32	1.56	0.78	1.71	0.00	0.00
pons, adult, pool1	10033-101E6	20.31	15.75	6.97	1.89	1.46	1.03	1.12
postcentral gyrus, adult, pool1	10032-101E5	37.14	18.48	10.03	4.97	2.62	0.87	2.18
promyelocytes/myelocytes PMC, donor1	12132-128D8	12.55	27.19	14.64	4.18	0.00	4.18	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	5.51	11.02	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	15.00	8.89	0.58	3.20	0.87	0.00	0.29
prostate cancer cell line:PC-3	10439-106E7	18.15	16.34	2.36	3.09	1.27	0.00	0.18
prostate, adult, pool1	10022-101D4	15.24	16.32	3.45	1.36	2.09	0.18	0.45
putamen, adult, donor10196	10176-103C5	47.68	16.52	11.80	6.61	1.89	0.00	0.71
putamen, adult, donor10252	10152-102I8	15.69	15.69	5.88	0.00	5.88	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	9.84	2.19	2.19	0.00	1.09	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	29.48	8.46	4.59	5.80	1.69	0.48	0.00
putamen, newborn, donor10223	10365-105F5	12.74	5.25	3.00	3.00	2.25	2.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	9.89	13.38	2.04	0.87	1.16	0.29	0.29
rectum, fetal, donor1	10067-101I4	30.60	16.69	4.17	4.17	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	5.51	5.94	1.06	1.06	1.70	0.00	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	13.25	4.97	0.00	1.24	0.83	0.41	0.41
retina, adult, pool1	10030-101E3	32.80	23.36	5.86	3.88	2.68	0.30	0.70
retinoblastoma cell line:Y79	10475-106I7	11.17	5.20	2.08	1.30	1.56	0.00	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	12.05	4.06	0.98	2.09	0.49	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	25.59	13.22	2.53	2.25	2.81	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	9.85	9.85	0.00	1.52	0.00	0.76	0.76
salivary acinar cells, donor1	11771-123I7	15.86	8.74	1.78	1.94	1.62	0.16	0.00
salivary acinar cells, donor2	11772-123I8	29.60	27.81	4.27	3.44	4.96	0.83	0.83
salivary acinar cells, donor3	11773-123I9	35.75	47.67	1.32	3.31	3.31	0.00	0.00
salivary gland, adult, pool1	10093-102C3	14.87	8.58	1.72	0.57	0.57	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	23.02	16.95	1.85	2.95	2.78	0.17	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	22.69	13.28	2.00	2.47	2.23	0.12	0.35
seminal vesicle, adult	10201-103F3	22.22	7.41	2.12	3.70	3.17	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	5.34	5.59	0.24	0.73	0.49	0.24	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	10.07	7.55	1.01	1.01	1.51	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	11.04	12.04	0.00	1.00	2.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	16.79	36.80	3.09	2.01	3.49	0.00	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	11.83	9.84	1.33	1.22	1.55	0.33	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	12.52	9.93	1.55	1.68	1.03	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	1.42	2.13	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	10.91	15.23	3.84	1.32	0.60	0.00	0.24
skeletal muscle, fetal, donor1	10066-101I3	37.19	9.05	2.01	3.02	3.02	0.00	0.00
skin, adult, donor1	10074-102A2	54.28	67.85	6.79	6.79	6.79	0.00	6.79
skin, fetal, donor1	10065-101I2	23.36	15.15	1.89	1.26	1.26	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	28.02	19.01	3.00	5.67	4.00	0.67	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	16.39	7.88	1.26	0.95	0.95	0.00	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	35.08	9.64	2.31	11.56	2.31	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	25.38	12.03	2.47	2.14	2.31	0.00	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	14.64	11.42	1.29	2.57	1.45	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	62.98	11.11	3.49	5.23	4.14	0.00	0.44
small intestine, adult, pool1	10024-101D6	26.52	26.04	6.57	2.99	3.11	0.48	0.60
small intestine, fetal, donor1	10064-101I1	22.60	18.43	2.70	1.72	1.72	0.00	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	15.39	15.39	3.59	0.51	1.03	1.03	0.51
smooth muscle, adult, pool1	10048-101G3	15.77	10.34	1.81	1.55	1.29	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	17.42	6.43	1.61	3.22	1.07	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	13.99	24.78	4.36	2.75	1.15	0.00	0.46
spinal cord, adult, donor10252	10159-103A6	15.38	26.81	5.13	2.37	1.58	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	7.61	1.38	2.08	0.69	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	35.98	37.20	12.20	5.49	5.49	1.22	1.83
spinal cord, newborn, donor10223	10359-105E8	8.27	11.94	3.67	2.30	1.38	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	9.71	5.23	0.15	1.49	0.90	0.00	0.00
spleen, adult, pool1	10025-101D7	17.18	26.87	2.09	1.54	2.31	0.00	0.99
spleen, fetal, pool1	10044-101F8	22.01	32.81	4.21	1.83	3.81	0.24	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	12.21	9.11	1.14	2.17	1.14	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	16.52	9.87	0.57	2.85	1.14	0.19	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	20.97	9.09	3.15	3.49	1.75	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	5.47	11.73	0.78	0.78	0.39	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	18.57	20.82	7.43	0.90	3.04	0.79	1.80
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	11.86	7.20	0.42	0.85	3.39	0.42	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	12.69	8.04	0.85	1.27	1.27	0.00	0.00
stomach, fetal, donor1	10062-101H8	23.50	16.02	2.14	2.14	2.14	0.00	0.00
submaxillary gland, adult	10202-103F4	14.24	12.53	2.28	2.28	2.28	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	22.43	37.18	4.57	1.45	2.08	0.00	1.04
substantia nigra, adult, donor10258	10371-105G2	16.55	2.59	2.07	0.00	0.00	1.55	0.52
substantia nigra, newborn, donor10223	10358-105E7	16.96	15.54	4.95	2.83	2.12	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	17.65	12.84	3.21	3.90	1.15	0.46	0.69
temporal lobe, adult, pool1	10031-101E4	38.91	24.16	12.38	5.17	3.39	0.68	2.46
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	70.51	13.53	7.83	10.68	3.56	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	57.14	9.67	8.35	6.59	4.83	0.44	0.44
tenocyte, donor1	11763-123H8	14.31	5.93	0.00	1.75	2.44	0.00	0.00
tenocyte, donor2	11765-123I1	20.60	9.54	0.76	1.14	1.91	0.76	0.38
tenocyte, donor3	11768-123I4	15.57	6.30	0.00	1.85	1.11	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	9.01	10.54	1.87	1.70	1.19	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	20.96	9.87	1.23	2.47	1.08	0.15	0.31
teratocarcinoma cell line:PA-1	10807-111A6	10.38	11.16	2.94	1.39	2.48	0.31	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	16.00	29.07	4.19	1.52	4.19	0.38	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	31.39	14.75	3.78	4.54	5.67	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	14.07	19.63	3.93	1.85	3.38	0.44	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	22.80	10.10	1.95	0.00	4.89	0.65	0.00
testis, adult, pool1	10026-101D8	28.67	17.39	43.06	6.33	4.19	2.68	0.86
testis, adult, pool2	10096-102C6	46.91	16.69	69.92	9.02	10.37	5.86	0.90
thalamus - adult, donor10196	10168-103B6	16.56	14.35	1.10	0.00	3.31	0.00	0.00
thalamus, adult, donor10252	10154-103A1	25.94	39.23	7.35	2.19	2.81	0.16	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	6.16	1.54	0.00	0.00	3.08	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	15.65	12.02	4.78	1.98	1.81	0.16	0.16
thalamus, newborn, donor10223	10366-105F6	12.08	6.33	2.88	0.58	1.15	0.58	1.15
throat, adult	10209-103G2	17.48	14.48	2.00	2.00	1.25	0.25	0.25
throat, fetal, donor1	10061-101H7	23.16	17.67	4.88	2.74	1.52	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	12.32	9.14	0.99	3.18	1.99	0.00	0.40
thymus, adult, pool1	10027-101D9	39.77	20.08	5.17	4.77	5.27	0.70	0.80
thymus, fetal, pool1	10043-101F7	38.96	29.82	5.30	3.53	3.84	0.42	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	13.03	7.05	0.93	2.13	0.66	0.13	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	12.15	6.43	0.70	1.54	0.84	0.00	0.28
thyroid, adult, pool1	10028-101E1	24.17	21.37	3.64	1.68	3.55	0.47	0.28
thyroid, fetal, donor1	10060-101H6	29.27	16.87	2.64	4.22	3.95	0.53	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	3.08	6.16	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	17.91	28.61	3.26	1.86	2.79	0.23	0.70
tongue, fetal, donor1	10059-101H5	17.73	19.70	1.18	2.36	3.15	0.00	0.00
tonsil, adult, pool1	10047-101G2	27.85	21.84	3.01	2.50	2.91	0.00	0.30
trachea, adult, pool1	10029-101E2	12.02	16.11	1.39	1.55	1.88	0.25	0.16
trachea, fetal, donor1	10058-101H4	16.93	16.16	1.54	1.92	3.46	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	6.38	9.57	1.06	1.42	1.77	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	12.36	12.16	2.53	1.52	1.32	0.51	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	39.02	11.44	2.19	5.48	5.80	0.47	0.16
tridermal teratoma cell line:HGRT	10694-109G1	9.51	3.81	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	15.07	18.96	1.10	1.27	2.54	0.08	0.51
umbilical cord, fetal, donor1	10057-101H3	25.04	20.87	0.00	2.09	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	29.01	25.25	3.07	1.02	4.10	0.00	0.85
uterus, fetal, donor1	10055-101H1	29.18	17.92	1.54	2.56	0.51	0.00	0.00
vagina, adult	10204-103F6	15.51	24.56	3.88	0.65	3.23	0.65	0.65
vein, adult	10191-103E2	17.54	22.80	3.29	2.19	1.32	0.22	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	8.81	6.41	0.27	2.40	1.60	0.27	0.00